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ABSTRACT 
The validation stage in the development of a medical device plays a critical role 
as it demonstrates that the new product meets all the functional, reliability and 
quality requirements of both customer and regulatory authorities. Operating 
under a highly constrained process, where multiple requirements must be 
satisfied, the identification and implementation of innovative and improved 
methods can result in great cost and time savings. 
This project aims to develop a highly reliable and efficient procedure for the 
validation of medical devices. In order to achieve this, a qualitative approach 
has been adopted and a benchmarking study has been performed within the 
aerospace sector with the purpose of identifying and adapting the best practices 
into medical device validation procedures. The organisation current practices 
have been reviewed in order to identify improvement opportunities. Through 
several methods, including interviews, extensive literature and publications 
review, leading practices have been identified and proposed to the organisation. 
Finally, the implementation guidelines for the new procedures are provided in 
this research project. 
The outcomes of the study showed that the development of some critical 
procedures within the organisation, combined with an adequate resources 
allocation result in performance improvements and time-and-cost savings for 
the validation process. These results provide a starting-point for future studies 
basing on a quantitative approach and the particularisation of the benchmarking 
study scope.  
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1. INTRODUCTION 
In the development process of a new medical device, the validation stage plays 
a critical role. At this phase, the commercial production and put-into-market of 
the final product depends on the success of this cost and time consuming 
critical phase.  
This project is part of the company initiative to develop new methods and 
improve the current procedures involved in the validation and qualification 
process of the medical devices it is manufacturing. 
For achieving this objective, a cross-industry benchmarking study within the 
aerospace sector has been selected in order to identify the best practices for 
this stage of the product development. 
Despite being at first glance two different sectors, they both share some points 
in common; both are highly regulated industries, working under exceptionally 
high standards of quality and safety and where the final performances of the 
product are critical for complying with customer and end-user requirements. 
Taking into account all the similarities and focusing on the elements that could 
be developed, it has been concluded that a cross-sector benchmarking study 
will be an enrichment process that will assist a medical device manufacturing 
company to achieve a more efficient, time and cost effective validation process, 
while ensuring all the regulatory compliance and meeting customer quality 
expectations. 
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1.1.  BACKGROUND AND MOTIVATION OF THE PROJECT 
In the development process of a new product by a medical device 
manufacturing company, the validation and qualification stage plays a critical 
role; at this point the commercial production and time-to-market of the final 
assembly depends on the success of this cost and time consuming phase. It 
represents the last metres of a long-run race, where all the resources and 
efforts need to be pushed into in order to cross the finish line and commercialise 
a device which fulfils the regulations and satisfies safely and successfully all the 
customer requirements. 
Moving within a highly constrained process, where multiple and nature different 
requirements from the involved parts (production, facilities, customer, industry & 
government regulations, etc.) must be satisfied; the improvement or 
development of innovative and more efficient methods can result in great cost 
and time savings for the whole production process. 
Under this particular working conditions and project environment, performing a 
benchmark research for the best practices is always an exciting and unique 
opportunity of learning new things, find new and innovative paths to face the 
existing problems and lead the changes to higher level performances and time 
and cost optimised solutions. 
In addition to this, although performing a benchmarking study of the internal 
industry and competitors would have been a useful solution, the decision of 
carrying out a cross-sector study supposes an even greater challenge to this 
project and increases vastly the learning opportunities. The sum of all this 
elements results in a complex and multidisciplinary activity which requires 
strong commitment and high motivation. 
The source of the motivation starts in the interest of undertaking a challenging 
project and take part in a unique opportunity for innovation by proposing new 
approaches and translating the best techniques and practices from one sector 
into another. 
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1.2.  SPONSORING COMPANY 
JEB Engineering Design Ltd (JEB), based at Mildenhall, Suffolk, is a leading 
company within medical device sector, focused on precision press tool design 
and manufacturing coupled with component manufacture. 
With 40 years of experience, JEB offers efficient solutions to multi-part complex 
assemblies manufacturing, providing their accumulated expertise in different 
manufacturing technologies, including laser resistance welding and plastics 
moulding. The organisation supplies to a diverse range of high-technology 
industries such as: 
- Computer hardware, electronics and Information Technology. 
- Medical devices 
- Automotive 
- Domestic electrical / white goods 
- Ammunition 
The Low Carbon KEEP (Knowledge-East of England-Partners) programme, in 
collaboration with the European Regional Development Fund (ERDF) scheme, 
provides support to East of England business focused on innovation and 
knowledge transfer, by improving the organisations’ internal capabilities and 
increasing their competitiveness by undertaking the following projects: 
- Development of new products, processes or procedures and efficient 
business solutions focused on reducing costs 
- Delivering programmes to improve resource efficiency, reduce  
consumption and operating costs 
- Reducing the environmental impact, attaining regulatory compliance and 
implementing sustainable development strategies. 
1.3.  SCOPE 
From the different elements and players involved in the previous lines, where 
the aim and objectives of this project were defined, a great variety of definitions, 
meanings and conclusions could be extracted. In order to avoid any ambiguities 
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and establish a clear and well-defined path for this research project, the 
definition of the scope of the study is required. 
The elements that are included in the scope are listed below: 
• Medical devices manufactured by JEB 
• Validation and qualification process related procedures 
• Aerospace industry verification and validation processes. 
As the elements described on the lines above might result quite general, some 
clarifications are made below. 
JEB is a precision tooling and component manufacturing company involved in 
different business areas (electrical components, ammunition, conversions), so 
many of the improvement requirements and findings could be applied on these 
productions lines. However, this research project will be mainly focused on the 
manufacturing of medical devices. 
Following the same actuation line, many of the improvement areas and findings 
could be applied to different stages pre and post validation; but these will be 
considered as secondary objectives of the project. In addition to this, despite 
sharing the same principles and philosophy of the validation structure, software 
validation is not included within the scope. 
Finally, this study and the field-work experience were done for 2 particular 
medical product projects of the company. The results are fully applicable to 
further medical device validation projects.  
1.4.  AIM AND OBJECTIVES 
The aim of this project is to perform a benchmarking study of the best practices 
in the aerospace sector for developing an efficient process for the validation of 
medical devices. 
Four specific objectives were identified; which could be considered as the main 
stops of a roadmap and the genesis of the research methodology. 
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• Evaluate the current procedures and the several normative, industry 
standards and regulations framework for medical device manufacturing; 
looking for gaps and improvement areas. 
• Perform a cross-industry benchmark study of validation and qualification 
practices within the aerospace industry in order to identify best practices. 
• Carry out validation, embedding assessment and implementation 
feasibility analysis of the identified methods.  
• Develop a set of guidelines with proposals for the implementation of the 
new practices. 
1.5.  SUMMARY 
This first chapter of the thesis has presented an introduction to the research 
project. The background of the research area of learning aerospace best 
practices for improving medical device process validation is described, 
highlighting the motivation for the project. The sponsoring company, JEB 
Engineering Design Ltd is introduced and the scope, aims and objectives of the 
project are stated. 
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2. LITERATURE REVIEW 
The objective of this chapter is to provide a general view of the available 
literature sources that cover the different concepts and basis of the elements 
involved in this project and any previous research that has been done. 
2.1.  BENCHMARKING THEORY AND PRACTICE 
2.1.1.  Definition 
The main motivation behind different companies around the world decided to 
start a analysis and comparison campaign may be found in Codling’s (1998) 
definition, where benchmarking is introduced as a “powerful tool for gaining and 
maintaining competitive advantage”, resulting in an tool which drives to the 
“best practice continuous improvement through an organisation”. 
A similar definition is given by Andersen and Pettersen (1996), who defined 
Benchmarking as a “tool for improvement”. It can be concluded from these 
statements that benchmarking is a tool of the company. It should be considered 
as a technique for achieving a specific objective (improvement) and not as a 
goal itself or the solution to all the problems of the organisation. 
The next figure (Dolan, 2003) demonstrates this fact and shows that 
benchmarking is the main process improvement tool used within organisations. 
 
Figure 2.1. Top 10 Process Improvement Tools in use (Dolan, 2003) 
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Finally, this introduction paragraph can be closed with the final definition of the 
benchmarking concept, which is considered as a standard among a large 
number of companies and cited by Watson (1993): 
“Benchmarking is a systematic and continuous measurement process; a 
process of continuously measuring and comparing an organisation’s business 
process against business process leaders anywhere in the world to gain 
information which will help the organisation take action to improve its 
performance”.  
2.1.2.  Types 
According to Andersen and Pettersen (1996), depending on what is compared 
and whom it is compared, several types and combinations of benchmarking 
practices can be identified. 
Through the vast literature about this classification, it can be pointed out that 
there are mainly four types of benchmarking which are predominant within the 
different sources and authors. (Camp, 1995; Andersen and Pettersen, 1996): 
- Internal Benchmarking 
- Competitive Benchmarking 
- Functional or Industrial Benchmarking 
- Generic Benchmarking 
Camp (1995) considers Internal Benchmarking as the starting point of the 
research study and a pre-requisite to a further external benchmarking, assisting 
in identifying the main operations and critical points and will expose the 
organisation practices for future developments (Crom, 1996). The basis of the 
internal benchmarking relies on the idea of understanding the own process and 
measuring the performances prior to undertaking any comparison with others. 
However, as it could be considered the easiest and fastest, according to the 
matrix on Figure 2.3 it provides the lowest level of expected benefits. 
Competitive and Functional Benchmarking both look on the same industry 
sector for comparisons, improvement opportunities and advantages (Elmuti et 
al., 1997). For the competitive case, the benchmarking partner will be easy to 
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find, but the availability of the information will depend on the willingness to 
cooperate and requires careful consideration (Camp, 1995). On the other hand, 
the Functional Benchmarking seeks for comparisons focusing on similar 
functions within the same sector, where the partners may share common 
technological or market characteristics (Elmuti et al, 1997). An accurate 
definition is given by Camp (1995), as “a comparison of practices at companies 
with similar processes in the same function but outside the industry”. The most 
common example of Functional Benchmarking success would be the Xerox 
case, who improved its practices by learning from outdoor specialist resulting in 
a significant reduction of costs, time and an increase of the quality (Camp, 1995; 
Cross et al., 1996). 
The Generic Benchmarking compares processes across companies and 
organisations from different industries or sectors. An excellent example of this 
practice may be the Dupont’s case (Camp, 1995); where an ammunition 
manufacturing company, in order to improve the surface finish of their product, 
selected lipstick producing companies as comparison partners. “Finding 
companies in totally unrelated industries that perform similar processes as 
oneself might sometimes a solid portion of creativity”(Andersen and Pettersen, 
1996) This study requires a careful and insightful understanding of the 
procedures (Elmuti et al, 1997), implies a broad and extensive 
conceptualisation and innovative “out-of-the-box thinking attitude” (Codling, 
1992). 
The next figure, as part of McDonnell Douglas Aerospace Benchmarking 
procedures (BMP, 1995), compares the different benchmarking types with the 
time required to conduct the study, cost and the capability. 
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Figure 2.2. McDonnell Douglas Benchmarking Hierarchy Model (BMP, 1995) 
Finally, the following figure (Andersen and Pettersen, 1996) shows in a matrix-
display the possible combination of benchmarking processes depending on 
what we are comparing (the organisation’s performance, a particular process or 
the strategy of the company) and whom we are comparing. In addition to this, it 
also reveals what combination of the different techniques is supposed to 
proportionate the best and most valuable results for the research. 
 
Figure 2.3. Benchmarking Matrix: Expected benefits (Andersen and Pettersen, 1996) 
Internal
Benchmarking
Competitor
Benchmarking
Functional
Benchmarking
Generic
Benchmarking
Performance
Benchmarking
Process
Benchmarking
Strategic
Benchmarking
MediumLow High
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Basing on this figure and the considerations of the authors, it can be shown that 
Functional and Generic Benchmarking produce the highest value when they are 
used for evaluating and comparing an organisation’s process. From this 
conclusion, it can be stated that the object of this thesis, the comparison of 
medical device manufacturing and aerospace industries, has been the most 
appropriate selection and has the potential to provide useful result for the 
improvement of the current validation process. 
Finally, the selection of the benchmarking type may also depend on other 
factors, such as the organisation requirements, the nature of the process, 
available resources and internal support or the transferability of the information 
(Codling, 1992). In a general case, companies will start practising 
benchmarking with internal partners, progress to “external” practice partners 
and gradually over a period of time build up to benchmarking against the “best”. 
2.1.3.  Process 
In a similar way to the types of benchmarking, depending on the consulted 
publication and author several stages and configurations for a benchmarking 
process could be identified. 
As an example, the figures below show the 5-step (Plan – Search – Observe – 
Analyse – Adapt) process proposed by Andersen and Pettersen (1996) or the 
more specific and detailed 12-stages wheel published by Codling (1992) 
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Figure 2.4. Benchmarking Process Steps (Andersen and Pettersen, 1996) 
 
Figure 2.5. Benchmarking Process Wheel (Codling, 1992) 
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If a synthesis exercise is carried out and the several process models proposed 
by the literature are evaluated, a common way-to-proceed can be identified and 
classified into the following key components. 
- Plan 
This is a common stage identified by all the reviewed authors in this literature 
research. The experience through several benchmarking projects has shown 
that this is the most important phase, which defines the foundations of the study 
for an effective process guaranteeing good results (Andersen and Pettersen, 
1996). The key activities at this stage may include the selection of what to 
benchmark, the subject selection and deciding which would be the best data 
collection method (Codling, 1992). 
- Partners and Information sources 
At this stage, the definition of the criteria for benchmarking partners, the 
identification and the selection of the final partners is performed. Codling (1992) 
stresses that the word “partner” used throughout benchmarking reflects its 
cooperative emphasis, in contrast with the competitive analysis, which can be 
conducted without an existing agreement. 
Zairi (1996) advises that several major categories and classifications should be 
used when determining the benchmarking partners, including those with 
demonstrated performance, robust procedures and same objectives. Another 
important fact is that the identified partner should be able and have the will to 
share information and discuss the different practices. 
Finally, (Bendell, 1993) suggests that when performing a best practice 
benchmarking, the partners are selected regardless of business, industry sector 
or culture. However, Andersen and Pettersen (1996) advises that the “Halo-
effect” is something that should be taken into account; defining this as a 
psychological term which involves attributing too positive or negative traits to 
someone based on only one highly visible characteristic. 
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- Data Collection and Analysis 
This phase covers the data collection, comparison and evaluation activities. 
According to Codling (1992), both qualitative and quantitative nature information 
should be gathered; and the collection methods can vary from publications 
research, questionnaires, surveys or company visits (Bendell, 1993). The 
following table lists some of these sources of information. 
 
Table 2.1. Typical sources of information (Codling, 1992) 
Codling (1992) and Andersen and Pettersen (1996)advise that it can often be 
tempting to go directly to the more direct and exciting sources of information, 
but the importance of publicly available data should not be underestimated. For 
example, the United States Central Intelligence Agency (CIA) organisation 
performs extensive information collection, gathering large amounts of data on 
political, economic and military issues in several countries. A former head of the 
CIA, Richard Helms, recognised that more than 85 % of the intelligence 
provided by CIA originates from the analysis of public information. (Andersen 
and Pettersen, 1996) 
The following figure shows a classification of several data collection methods as 
implemented at McDonnell Douglas Aerospace (BMP, 1995). 
Data sources
INTERNAL EXTERNAL
Company Archives External libraries
Corporate publications Special reports and surveys
Databases External Databases
Internal surveys Media broadcasts/reports
Market Research Journals
Personal Networks Trade shows
Planning documents Professional networks
Financial documents Industry Experts and Analysts
Suppliers / Customers
Company reports
Consultants
Trade Associations
Professional Institutes
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Figure 2.6. Different modes of data collection (BMP, 1995) 
Once the different collection methods have been shown, the next doubt would 
be select the most appropriate one for the study purposes. Zairi (1996) lists the 
factors that influence this choice: 
• “Time limitations. If the information collection requires to be done in a 
short period of time, this might eliminate using benchmarking partner 
personal visits or live interviews”. 
• “Resource limitations, as the different techniques present different 
resource requirements with regard to financial and human resource 
aspects”. 
• “Experience, as the researcher usually tends to use the techniques that 
one is familiar with”. 
An interesting tool that is reviewed through all the literature is the use of a 
questionnaire. According to Andersen and Pettersen (1996), the advantages of 
using this method include the establishment of a framework that helps sorting 
and organising the information that needs to be collected, the clear definition of 
the information requirements and the areas of interest and finally, the 
construction of the questionnaire represents an excellent opportunity for raising 
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the participation of the personnel involved in the process that is being 
benchmarked. 
It is a common factor between the reviewed authors that the data that can be 
obtained can be divided into 2 groups: qualitative and quantitative information. 
Quantitative information (metrics, performance measurements) are useful 
indicators that show how processes and practices are working (Camp, 1995). 
These metrics will enable the identification of the company’s own performance 
for the selected process to benchmark and define the size of the gap that exists 
in comparison. Process measurement indicators should be carefully selected, 
ensuring that the comparisons are made on an “apples-to-apples” basis (Elmuti 
et al., 1997).If objectives are correctly and accurately defined, there will be less 
likelihood of diversions or wasted resources. 
However, depending on the characteristics and nature of the process that is 
being benchmarked, some metrics and quantitative data might be not available 
or non-comparable factors intervene in the comparison (Zairi, 1996). 
- Implementation and monitoring 
The following statement defines the relevance of the last stage of the 
benchmarking process: 
“If benchmarking goes no further than data collection, it has been a waste of 
time” (Fowler, 1997). All authors are unanimous with this opinion; the success 
associated to a benchmarking process comes ultimately from the 
implementation and not from the data. 
However, it is also broadly acknowledged that the implementation phase may 
result not to be easy. Organisations may not know how to successfully translate 
procedures or ideas (Elmuti et al., 1997). It is stressed (Camp, 1995) that new 
practices should not be imposed but adapted to the company. In addition to this, 
a last requirement of benchmarking would be the necessity of evaluate and re-
calibrate benchmarking as an iterative process. 
Another advice on the implementation phase is “to adapt, not adopt” (Andersen 
and Pettersen, 1996). “After having observed methods that function very well in 
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the partner’s organisation, it might be tempting to adopt it directly into our own 
procedures”.  If so, the fact that there might be certain conditions that make the 
method work well for the partner might be overlooked. These conditions include 
market characteristics, industry, organisational structure, etc. The identified 
methods must be adapted to fit the conditions present in one’s own 
company.(Codling, 1992) 
During the implementation phase, it is also need to be reminded (Andersen and 
Pettersen, 1996) that all changes are painful to those affected by and the 
psychological effects that such implantation might have on the human 
resources should be considered. Miller et al. (1992) suggests that the best way 
of easing this discomfort, and increase the probability for success, is to let the 
personnel affected by the changes to take part in the decisions that are going to 
be made by permitting their representation in the benchmarking team. 
2.1.4.  Best practices and benefits 
A term which may come out on several occasions when reviewing the literature 
about benchmarking is best practices. Camp (1995) advocates that the best 
practices are the ones that “lead a company to a superior performance”. Zairi 
(1996) states that best practice comparisons are the ones that potentially spark 
improvements that may provide the most significant rewards and returns. 
As a further development of this definition, Codling (1992) advises that such 
“best” practices depend on the nature of the process and the requirements of 
the company and it could vary depending on these. For example, when buying 
a new car, the characteristics of the “best car” may differ depending on the 
subject (family with children, company use), purposes and the available 
resources. This concept can be illustrated with the following figure, which 
represents Codling’s statement. 
17 
 
 
Figure 2.7. Search for the Best Practice. 
When evaluating the benefits that the benchmarking process may bring to an 
organisation, the reviewed authors provide several of them. According to Elmuti 
et al. (1997), this process can support the strategic planning and encourage the 
development of new performance and productivity measures. Furthermore, 
Camp (1995) advises that an approximate image of a company’s situation 
within the industry can be obtained through this method and such; taking 
advantage of such awareness for enhancing the strong points and reinforcing 
the weaknesses. 
  
COMPANY
Practice 1
Practice 2
Practice 3
Practice 4
Best practice?
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2.2.  MEDICAL DEVICE VALIDATION 
The literature review of the basis and practices of medical device validation 
practices starts, logically, with the definition of the elements of this title. 
According to Nishihata (2003), a medical device is generally defined as: 
“An implant and equipment to be used either to achieve disease diagnosis, 
medical treatment, or disease prevention or to influence the physical structure 
and function” 
As it can be seen, this definition covers a wide range of categories, starting from 
scissors and other minor surgical equipment, which represent small risk to 
human function; to intravenous catheters, dialysis devices or pacemakers, with 
a high risk and responsibility to human function and life (Nishihata, 2003). 
On the other hand, for the validation part, we may recur to the U.S. Food and 
Drug Administration (FDA), the regulatory agency responsible for supervising 
the public health related issues in the United States and the main (in terms of 
influence) regulatory organism within the medical device global industry, who 
defines it as a “method for assuring that a product manufactured satisfies the 
design required, the specification established and the reproducibility of the 
results” (FDA, 2011). 
Comparing these two definitions, we can foresee that the elements implicit in 
both contexts are tightly linked by the existing requirements and normative that 
regulate their reason-to-be. 
Prior to the review of the different concepts involved in validation and process 
validation, the industrial context will be introduced with the following figure (PTC, 
2008); which illustrates a generic medical device development process showing 
the process involved in the development of a new product, the stages 
throughout this product advances and the functional departments in charge of 
the activities of each stage. 
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Figure 2.8. Product Development Process (PTC, 2008) 
2.2.1.  Validation principles 
By performing a quick overview on the different industry regulations and quality 
standards, it can be pointed out that process validation is a basic requirement in 
heavily regulated industries, such as automotive or aerospace (Weese, 1998). 
In the case of medical device manufacturing, both the International Organisation 
for Standardization (ISO) and the United States Food and Drug Administration 
(FDA) require process validation as a regulatory requirement (Dixon et al., 
2006). 
In order to explain the reason of this requirement, some previous general 
concepts will be introduced. The first one will be the assurance of product’s 
quality. Quality control is a vastly treated and reviewed concept and by 
referencing some of its experts, it could be introduced as assuring a product’s 
services, cost control, production, delivery, safety and other performances (Dale 
20 
 
and Tidd, 1991) or by the costs related to the lack of quality, which will 
eventually result in society’s losses caused by that particular product after its 
delivery (Taguchi, 1989). 
Assurance of a product quality consists of several factors, such as selecting 
quality parts and materials, defining an adequate design or controlling the 
process and final testing (Juran, 1974). Due to the complexity of medical 
products, the total control of these different features and the routine testing of 
the end-product often are not sufficient to assure product quality. Some of the 
tests have a limited sensitivity and in other cases only destructive testing would 
show that the manufacturing process was adequate (Kuba, 2003). 
Within the production of a product, some quality goals are required to be 
reached, which are listed in 3 principles: (1) “quality, safety and effectiveness 
must be designed and built into the product”; (2) “quality cannot be inspected or 
tested into the finished product” and (3) “each step of the manufacturing 
process must be controlled to maximise the probability that the finished product 
meets all quality and design specifications”. This is why validation is a key 
element in assuring that these quality assurance goals are totally met (FDA, 
1987). 
These concepts can be summarised as follows: the product that results from a 
process should be verified to demonstrate that it meets the specified 
requirements. For the requirements that can be verified, a verification stage will 
be established (inspection, test, etc.). For the requirements that cannot be fully 
verified, a validation process will be required. (O’Leary, 2010) 
 
Figure 2.9. Requirements verification and validation (O’Leary, 2010) 
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The next question that may rise from this definition might be which processes 
should be validated. 
A general answer for this question can be found on FDA’s Quality System 
Regulations Manual (21 CFR Part 820 QSR) (FDA, 2008), which states that 
validation should be performed in the following cases: 
- “Routine end-product test have insufficient sensitivity to verify the desired 
safety and efficacy of the devices.” 
- “Routine end-product test do not revel all variations in safety and 
efficacy.” 
- “Clinical or destructive testing would be required to show that the 
manufacturing process has produced the desired product or result.” 
- “Process capability is unknown or it is suspected that the process is 
barely capable of meeting the specifications”. 
In order to illustrate on a better way these conditions and provide some specific 
examples, a reference should be done to the Global Harmonization Task Force 
(GHTF), a group of representatives from medical regulatory authorities with the 
objective of standardise medical device regulations across the world. According 
to this organisation, the following processes shall be validated:“sterilisation, 
clean room environment conditions, sterile packaging, heat treating, plastic 
injection moulding or laser welding” (GHTF, 2004). 
 
Figure 2.10. GHTF Decision Tree: What requires Validation (GHTF, 2004) 
IDENTIFY PROCESS FOR 
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VERIFICATION
Process 
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A more general description could be found on the abovementioned 21 CFR Part 
820 QSR (FDA, 2008), which states that routine end-product test that have 
insufficient sensitivity to verify the desired safety and efficacy,  
Finally, a last question that should be answered is: “What are the main 
differences between a common process and a validated process?” Recurring to 
O’Leary (2010), a typical process within engineering is composed of: 
- Process specifications or requirements (predetermined) 
- Product specifications (predetermined) 
- Work instructions 
- Suitable Equipment 
- Monitoring and measuring procedures 
- Product verification 
In the case of validated processes, they also have: 
- Process parameter controls 
- Qualified operators 
- Additional record-keeping requirements 
2.2.2.  The validation process 
Continuing with the FDA definitions, under its Good Manufacturing Practice 
(FDA 1987; FDA 2011) the term validation process is clearly stated as 
“establishing documented evidence which provides a high degree of assurance 
that a specific process will consistently produce a product that meets 
predetermined specification and quality attributes” (FDA, 1987). 
More recently, the FDA updated this definition in the following revision of the 
Process Validation Guidance (FDA, 2011), defining process validation as “the 
collection and evaluation of data, from the process design state throughout 
production, which establishes scientific evidence that a process is capable of 
consistently delivering quality products”. 
At this point, in both definitions, a critical concept of the validation process is 
introduced, the terms “documented evidence” and “collection and evaluation of 
data”. As it will be seen later, all the activities related to documentation 
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(generation, record, traceability) are the key foundation where all the process 
relies on. 
Quoting back the FDA, it is important that the manufacturer prepare a written 
process that specifies all the procedures to be conducted, capable of collecting 
and reflect accurately all the required information (FDA, 1987). 
Returning to the central subject, the following figure represents the different 
stages and key milestones of the validation process of a medical device. 
 
Figure 2.11. Medical Device Validation process (Tejal, 2011) 
Three key stages can be appreciated in this process are according to Dixon 
(2006): 
- Installation Qualification (IQ), “where the key aspects of the equipment 
installation, supplies, calibration, maintenance and operator training are 
established”. 
- Operational Qualification (OQ), “which demonstrates that the equipment 
consistently operates to specification under normal conditions, including: 
testing of alarms, software function, machine consistency and extremes 
of operating ranges”. 
- Performance Qualification (PQ) “produces product within specification 
when operated under the defined conditions”. 
The process start with the development of the (design), which is applicable for 
both the product, the manufacturing process (tooling) and the test methods, 
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which should include accuracy for manufacture and testing and safety for 
preventing contamination (Nishihata, 2003). 
The core purpose of the IQ is to show that the equipment and facility used to 
manufacture, measure and test the product is maintained and calibrated as 
required (Stockdale, 2010). In addition to this, it provides the opportunity to 
evaluate the specific installation and process conditions that can prove valuable 
over the programme. For example, if a process is not yielding the same 
dimensional stability after some time, installation qualification can be tracked to 
obtain the circumstances of the problem. By documenting the initial settings of 
the installation, the investigation to determine the root cause of the rejects will 
be simplified (Stockdale, 2010). 
The following bullet-points, by O’Leary (2010), summarises the IQ phase: 
- “Equipment must meet specified requirements” 
- “Equipment should be installed so it can be operated and maintained.” 
- “Limitations and tolerances are easily known by the operator” 
- “Work Instructions are available” 
- “If the equipment has a measuring function, include the calibration 
schedule”. 
The objective of the OQ is to evaluate and define the manufacturing process. 
Through the use of analytical processes, engineering studies and statistical and 
dimensional evaluations, one can identify areas of concern that need to be 
addressed early in the programme (Stockdale, 2010). Definitions from the 
relevant normative and regulatory bodies may include “establishing documented 
evidence that the process is effective and reproducible” (FDA, 2008) or 
“establishing by objective evidence that the process control limits and action 
levels which result in product that meets all predetermined requirements” 
(GHTF, 2004).Again, it is pointed out the stress made on establishing 
documented evidence. 
The Determination of Experiment (DOE) is used to define which process 
parameters affect specific dimensional responses, the influence on the 
response and the interactions between them; establishing the optimum process 
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window and its respective influence on each dimension. From these studies, the 
predicted dimensional outcome can be confidently defined. During the DOE, a 
series of experiments are carried out and the influences are evaluated 
statistically (Dixon, 2010). 
 
Figure 2.12. Operating points example: DOE for the optimal dimensional process window 
(O’Leary, 2010) 
These process limits will then be challenged and evaluated. The challenges 
consist of three dimensional runs: low, high and nominal process challenge runs. 
Each run is equal in run time and evaluated for dimensional, functional and 
cosmetic considerations in relation to the product specifications and tolerance. 
The results may demonstrate conditions that do not meet the desired 
acceptance criteria, in which case the process tolerance, mould or specification 
needs to be modified and if necessary, the processes re-run to verify 
conformance. (Rifino, 2003) 
A description of the Performance Qualification (PQ) can be given by the GHTF 
(GHTF, 2004), which defines it as “establishing by objective evidence that the 
process, under anticipated conditions, consistently produces a product which 
meets all predetermined requirements. In other words, it consists in 
demonstrating that the process, under anticipated conditions, consistently 
produces conforming product”. 
Once that the different stages of the process validation of medical devices have 
been described, the next point would be explaining how these process is 
actually carried out in practice. A summary of these actions are given by 
O’Leary (2010): 
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- Determine the need to validate 
- Determine what to validate (IQ-OQ-PQ) 
- Write a Validation Protocol 
- Conduct the Protocol and collect the data 
- Analyse the data 
- Improve the process, based on the data and analysis 
- Prepare a report 
- Keep documentation as a Quality Record 
Finally, some controversial opinions of the pharmaceutical industry about the 
validation process are worth to be mentioned in this literature review. As 
Johnston (1995) points out, “it (process validation) has been considered that the 
blind, bureaucratic approach to validation followed by some companies is a 
needlessly expensive process that achieves nothing more than a temporary 
reprieve from the regulatory authorities”. 
Many medical device manufacturers consider validation and other regulatory 
requirements as a “dead weight or burden”. While some companies have 
developed a “mature approach to regulatory compliance and have acquired an 
integrated approach and methodology, many other companies in the sector only 
consider the validation aspect once the main elements of product and process 
have been completed” (Johnston, 1995). “If it is faced from this perspective, 
meeting the established regulations might become a paper generating exercise 
and a drain on resources” (Baseman, 2012). “However, these requirements 
should be taken as an opportunity to increase process understanding, ensure 
that processes are operated under optimum conditions, improve quality and 
reduce costs”(Dixon et al., 2006). 
Finally, an update to the process validation approach has been introduced 
within FDA’s latest document revision (FDA, 2011), where as a complement to 
what has been explained until now, a product life-cycle approach is considered, 
as it can be appreciated on the following figure. 
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Figure 2.13. Process Validation: Life-cycle approach (Baseman, 2012) 
The first stage is highly focuses on Process Design, in order to build and 
capture knowledge and understanding on process capability and variability from 
its development phase. The Design of Experiments to identify and establish the 
process parameters and sources of variability; and the risks assessment aim to 
minimise and prioritise efforts, are classified into this step. (Baseman, 2012) 
Stage 2, Process Qualification, comprises the most part of what have been 
introduced on the previous paragraphs of this section. During this stage, the 
process design is confirmed as being capable of reproducible commercial 
manufacturing (FDA, 2011). Activities of this stage include, as abovementioned, 
facility and equipment qualification (IQ) and process performance qualification 
(OQ, PQ). 
Finally, the loop is closed by Stage 3 with the Continuous Process Verification, 
where on-going assurance is gained during routine production that the process 
remains in a state of control (Baseman, 2012). 
With this new life-cycle approach, process validation should not be considered 
any longer just as a milestone, becoming now a continuous process of valuation 
(Long et al., 2011). These steps contribute to “know the process”, “know the 
variables”, “have confidence before going into commercial production” and 
create vigilance through monitoring and continuous improvement. 
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The challenges created on the medical device manufacturing organisations 
require these to expand their current scope of validation by reaching further 
upstream into development and downstream into day-to-day manufacturing 
(Long et al., 2011). It is commonly agreed that this will foster better 
communication from development through production. In order to face 
successfully this new challenge, the author suggest medical device companies 
to perform gap analysis of their current state of validation programmes and 
compare it with the future state based on the new guideline (Long et al., 2011). 
These assessments will provide a better position to organisations to create 
action plans and procedures for the new policies, as well as identifying any 
further resource or training requirements. 
2.2.3.  Quality Assurance role in the validation process 
The International Organisation for Standardization (ISO) defines Quality as the 
“measure of excellence or state of being free from defects, deficiencies and 
significant variations”. When applying this concept to manufacturing, Dale et al. 
(1991) states that it consists in the strict and consistent adherence to 
measurable and verifiable standards to achieve a uniformity of output that 
meets the requirements established by the customers or users. Juran (1974) 
defined Quality Assurance as the activity of providing to all the parts concerned 
the evidence required to establish confidence that the quality function is being 
managed adequately. 
As defined previously by the relevant authorities, the purpose of process 
validation is to show that a specific process will do what it is purposed to do 
(FDA, 1987; FDA, 2011; GHTF, 2004).  
Quality Assurance in medical device companies embodies the effort to ensure 
that the products have the reliability, safety and efficacy in performing as it is 
intended to do (Kuba, 2003). 
During the last years, this quality awareness has been stressed as companies 
seek world-class status for their operations defining QA programs focused on 
the following factors: certifying suppliers, setting standards for customer 
satisfaction (both within and outside the organisation) and incorporating several 
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process controls (i.e., Statistic Process Controls) in manufacturing operations 
(Cheng, 1994; Kumar, 2008) 
The activities and responsibilities of the Quality Assurance department within a 
medical manufacturing organisation are (Beckford, 2002; Rifino, 2003): 
- Establish raw material specifications and their acceptable limits: All raw 
materials are tested before use and these must meet quality standards 
and specifications, as well as their limits set. External contractors may 
perform these tests, but QA will ensure that the laboratory procedures 
are properly followed and documented, with the end objective of ensuring 
that no raw material is released improperly. 
- Product specifications and their acceptable limits: QA responsibilities are 
the same as for raw materials and final products. All finished products 
(including components and sub-assemblies) are tested to determine if 
they meet the required quality standards. 
- Product and process stability: stability programmes are performed to 
determine whether or not the product or component will be manufactured 
properly and maintain its quality characteristics through its operational 
life. 
- Training: Responsibilities associated with process validation and Quality 
Assurance relies on the training of the personnel involving in the 
manufacturing and testing activities. These personnel are trained to carry 
out the standard procedures required by validation documentation. 
- Documentation: Quality Assurance is responsible for generating all the 
documentation directly related to the process validation (protocol, report, 
data collection, etc.) in order to meet one of the main objectives of the 
process, to establish documented evidence. Other responsibilities 
include the release of manufacturing related documentation (procedures, 
work instructions) and other quality specific records. 
- Process Validation: This activity is concerned with controlling the 
manufacturing process, ensuring what procedures must be performed 
and under what conditions they must be carried out and establishing 
documented evidence that a process is reproducible and it will 
consistently produce a product meeting the specified requirements. 
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Rifino (2003) advocates that process validation should be considered the main 
tool of Quality Assurance because it not only involves the activities of different 
organisational units but also centres on proving that the process is under control. 
It provides documented evidence that the quality function exists for the 
manufacturing process. 
2.3.  VALIDATION IN THE AEROSPACE SECTOR 
The term validation within the aerospace industry context has a broad range of 
definitions and meanings, as contrast of the accurate definition given in the 
pharmaceutical and medical device industry. Despite sharing the same 
philosophy on its basis, it has no standardisation and its definition may vary 
depending on the sector (aviation, space, etc.) or the regulatory authority 
consulted. 
Throughout this section of the literature review, different approaches to 
validation in the aerospace industry will be introduced in order to establish and 
framework for the research activities. 
2.3.1.  Process Validation in aerospace 
This section will emphasise in the process validation concept, which is focused 
on the validation of the different manufacturing practices and it has been 
considered as the most related one to the medical device process validation. 
In aerospace industry, the validation of a process is regulated by the Aerospace 
Quality Standard AS9100, clause 7, sub-clause 5, section 2, validation of 
processes for production (SAE, AS9100 Rev. C).  
According to this section, in special manufacturing and production processes 
where verification or test is not possible or feasible, the validation of such 
process should be performed (i.e., composites, critical components, new 
manufacturing solutions, etc.). (SAE, AS9100 Rev. C) 
As an example of the application of this clause, these are the quality 
requirements that the aircraft manufacturer Embraer requires for its suppliers: 
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Figure 2.14. EMBRAER Quality Requirements for Suppliers (Embraer, 2010) 
The Federal Aviation Administration (FAA), a regulatory organism of the U.S. 
Department of Transportation in charge of regulating and oversee all aspects of 
civil aviation in the United States, on its Guidelines to Minimize Manufacturing 
Induced Anomalies in Critical Rotating Parts (2006) document, defines the 
process validation as “a procedure in which it is demonstrated that the 
manufacturing process delivers parts and product consistent with the form, fit 
and function required by the design of the part to meet its Service Life”(FAA, 
2006). According to the FAA, two approaches to Process Validation are used 
within the aerospace manufacturing industry: 
- Part Specific Process Validation (PSPV) 
- Generic Manufacturing Process Validation (GMPV) 
In PSPV, a part is evaluated against its design requirements and subsequent 
production is controlled to deliver product consistent with the evaluation (FAA, 
2006) 
In GMPV the manufacturing methods that are identified as being sensitive, or in 
other words, that requires a high level of control in the manufacturing process to 
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meet the design requirements are controlled by specifications and/or validated 
parameter limits. The GMPV ensures that any product manufactured within the 
parameter window will meet the design requirements (FAA, 2006) 
The FAA describes the procedure on the following table as a “route” to Process 
Validation for an engine component. 
 
Table 2.2. Route to Process Validation (FAA, 2006) 
Finally, this section is concluded with a case-study which will expose how 
process validation is carried out in the aerospace sector. This real case is 
described in the Best Manufacturing Practice: Centre of Excellence website as 
a best practice performed by the aerospace and defence company Lockheed 
Martin – Tactical Aircraft Systems (BMP: CoE website, Lockheed Martin). 
According to this database, Process Validation is used by Lockheed Martin “to 
meet the requirements of test environments, customer demands, concept and 
design review baselines and design standards, ensuring this way the accuracy, 
Step Who Activity How / Comments
1 EngineDesign
Identify parts which must maintain a high 
level of integrity to avoid hazardous 
engine effects and designate them as 
CRITICAL, FLIGHT SAFETY PART or 
LIFE CONTROLLED PART.
FMEA of the engine leads to part 
classification. 
The critical nature of the part should be 
conveyed to all parties concerned with 
manufacturing the part.
2 ValidationTeam
Review all part features and identify the 
features made by Sensitive Manufacturing 
Processes.
PFMEA or other disciplined method 
should be used to help identify Sensitive 
Manufacturing Processes.
It is generally accepted that the feature 
Manufacturing Process and fatigue life 
should be considered in the identification 
process. 
3 ValidationTeam
Validate the Manufacturing Process for 
those features identified in step 2.
The Process Validation can be a 
combination of:
- PSPV
- GMPV
3.1 Manufacturingengineer
PSPV:
Define
Manufacturing 
Process
GMPV:
Define parameter
limits
Based on validated manufacturing 
methods.
3.2 ValidationTeam
Establish fatigue 
capacity
Investigate the 
fatigue behaviour or 
parameter limits 
including 
consideration of the 
most adverse 
combinations
By fatigue test using part, sub-element or 
specimen which captures material, 
Surface Condition and geometry,
Or
Metallurgical evaluation where 
experience defines an acceptable 
material Surface Condition
Or
A combination of the above.
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repeatability and reliability of the process through analysis and independent 
verification” (BMP: CoE website, Lockheed Martin) 
The Process Validation “includes simulation and modelling, test validation plan 
and Production Readiness Assessment; which consists in assessing the factory 
and depot test equipment, production tooling, test procedures, calibration 
procedures, preventative maintenance plans and equipment operating 
instructions” (BMP: CoE website, Lockheed Martin). As it can be appreciated, 
there are clear similarities with the processes performed within the medical 
device validation. 
The benefits for Lockheed Martin that Process Validation approach presented 
consisted in “a reduction of test debug time, faster achievement of full-rate 
production, lower production support costs, verification of readiness of the 
production line, early availability of process variability data, verification of 
product testability and producibility and efficient production test flows”. (BMP 
website, Lockheed Martin) 
Because all process validation methods are integrated, “unnecessary test are 
eliminated, the number of test equipment required is reduced, the production 
bottlenecks are identified early in the manufacturing cycle and production costs 
are minimised” (BMP website, Lockheed Martin). 
2.4.  CROSS-INDUSTRY APPLICABILITY 
Finally, at this last section of the literature review, the procedures and practices 
that were originally created in the aerospace industry and were later adopted by 
the medical sciences sector have been exposed. It requires to be pointed out 
that previous publications about this subject were very limited, resulting in a 
potential gap that should be fulfilled. 
Owing to this fact, one of the contributions of this research project would be 
providing a framework and a set of initiatives that would allow current practices 
implemented in aerospace sector organisations to be translated and adapted to 
a medical device manufacturing company. 
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2.4.1.  Quality Systems framework 
A first approach could be made in this applicability evaluation exercise by 
comparing the ISO quality system requirements for both industries on the 
process validation related area. 
On one hand, the International Standard which specifies the quality 
requirements for the medical device manufacturing sector is the ISO 
13485:2003; which is based on the ISO 9000 quality standard series, by some 
additions and deletions it harmonises the existing requirements within the 
different authorities present in this industry. 
On the other hand, the quality standard for aviation, space and defence 
organisations worldwide is the AS 9100, being the Revision C the latest version. 
The main objective of this standard is to set a framework based on terms of 
confidence between suppliers and manufacturers (Graham, 2007). First 
published in November 1999 by the Society of Automotive Engineers (SAE), it 
was the first globally acknowledged system that addressed both military and 
civil aviation needs. Developed by a special advisory committee of ISO and 
other international quality groups, it contains the ISO 9000 quality standard 
series requirements with additional requirements which are specific to the 
aerospace industry. 
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Table 2.3. Quality Systems Comparison (ISO 9001:2008, ISO 13485:2003, SAE AS9100:2009) 
As it can be seen, at first sight, there are no big differences in the requirements 
of process validation from the quality standard point of view, other than the prior 
approval before entry into service in aerospace (no retrospective validation) and 
tighter process parameter controls. 
2.4.2.  Aerospace Reliability applied to Biomedicine 
The most subject-related publication is a paper titled “Aerospace Reliability 
Applied to Biomedicine” by Lalli and published in 1972. 
Through this article, the author suggests that the quality and reliability 
procedures used by the National Aeronautics and Space Administration (NASA) 
on their space rocket program applied on medical equipment may result highly 
beneficial. Lalli (1972) establishes along this article the several similarities that 
both sectors share and sets some basic-points for further development activities.  
The purpose of this paper by Lalli was to evaluate “the methodology developed 
by NASA to achieve equipment reliability”. According to the author, there are 
many obvious differences between the space and medical areas, “and much 
that is done to achieve reliability of space equipment is not directly applicable in 
Clause Requirement ISO 13485:2003 SAE AS9100:2009 Rev. C
7.5.2
Validation of Processes for 
Production and Service
Validation of Processes for 
Production and Service
Validation of Processes for 
Production and Service
The organisation shall validate any 
processes for production and 
service provision where the 
resulting output cannot be verified 
by subsequent monitoring or 
measurement. This includes any 
processes where deficiencies 
become apparent only after the 
product is in use or the service has 
been delivered
Same
Same
Note: This processes are frequently
referred as special processes
Validation shall demonstrate the 
ability of these processes to 
achieve planned results
Same Same
The organisation shall establish 
arrangements for these processes 
including, as applicable
a) Defined criteria for review and 
approval of the processes,
b) Approval of equipment and 
qualification of personnel,
c) Use of specific methods and 
procedures,
d) Requirements for records and,
e) revalidation
Same
Same, except for:
a) Defined criteria for renew and 
approval of the processes, 
qualification and approval of special 
processes prior to use,
c) Use of specific methods and 
procedures, control of the significant 
operations and parameters of special 
processes in accordance with 
documented process specifications 
and changes 
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the biomedical area. Much of the methodology should be of value”. (Lalli et al., 
1972) 
In this paper, “the Space Electric Rocket Test project is used as an example of 
NASA application of reliability and quality assurance methods” (Lalli et al., 
1972). By performing a direct comparison it is exposed “how the same methods 
can be used in the development of instrumentation and complex systems for 
use in medicine”. 
As it is pointed out by the author, both NASA and the medical industry are 
involved in the design, production and operation of complex and critical 
equipment. “These systems must operate accurately and reliably. Failure can 
cause economic loss; even worse, it can result in the loss of human life” (Lalli et 
al., 1972). This way, NASA has developed an extensive reliability and quality 
assurance methodology that could be used as the bases for an appropriate 
program for medical instrumentation. Such a program should be aimed at 
improving equipment performance, reducing failures and absolutely minimising 
risks of personal injury or death (Lalli et al., 1972). 
This research paper showed that a survey in some hospitals of the Detroit area 
disclosed many disturbing things about the medical devices: 
- “Few pieces of equipment are properly maintained” 
- “Simple calibrations and adjustments are not made” 
- “Dust is allowed to build up inside the chassis causing components to 
overheat” 
- “Few defibrillators accurately produce the amount of energy they are 
supposed to” 
- “Most monitoring oscilloscopes and electrocardiographs have a 
substandard frequency” 
In addition, medical equipment was found to contain the following defects: 
- “Low quality parts were used in construction” 
- “Planning in the placement of equipment was poor” 
- “Equipment was not adequately protected from its operating environment” 
- “Equipment was misused by being operated by untrained personnel.” 
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“To solve similar problems in achieving highly dependable equipment 
performance, NASA developed an extensive methodology for improving, 
maintaining and verifying design reliability and product quality of space-program 
hardware” (Lalli et al., 1972) 
This space-related methodology was based on the application of two existing 
engineering disciplines: 1) reliability, and 2) quality assurance. (Lalli et al., 1972) 
According to the author’s definitions, “reliability engineering is concerned with 
design and testing tasks in product development to ensure that the product is 
properly designed to perform the assigned task without failure” 
(VERIFICATION). On the other hand, “Quality Assurance is concerned with 
various control methods and qualification testing to ensure that the product 
delivered is manufactured as designed” (VALIDATION) (Lalli et al, 1972) 
Regarding this last aspect, the author provides an interesting statement related 
to the resources used during this stage: In quality assurance, “the best-
designed product is only as good as the people and materials finally used to 
make it” (Lalli et al., 1972) 
Another relevant stage within high complex products is the review of the 
specifications and requirements. As the author details, “specifications explain 
just what is required in each component in either case” (Lalli et al., 1972). The 
usual tasks required to be performed by quality-assurance engineers in this 
control activity are “1) drawing review 2) configuration review 3) procurement 
document review 4) vendor survey 5) fabricated article review 6) component 
identification system 7) preservation, packaging, handling, storage and shipping 
review 8) training and certification of personnel” (Lalli et al., 1972) 
The next steps taken for the evaluation of the Flight Status Review by NASA 
provides several aspects for ensuring the mission success. According to the 
American Space Agency, a flight component is considered to be flight ready 
only if the criteria given below are met (Lalli et al., 1972): 
1) Fabricated to the latest released specifications 
2) Meets all test requirements 
3) Date of fabrication, source, serial number and history are identified 
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4) “History does not contain repetitive repair, rework or modifications” 
5) “The life-limited equipment is identified” 
6) “Stable operation history without test anomalies” 
7) “Failures have been analysed and corrective actions taken” 
8) Corrective action has been inspected and tested to assure performance 
9) Condition not degraded by handling or storage 
10) “The replacement components are handled like flight items” 
11) “The launch-site activities are carefully planned to maintain readiness” 
Despite sharing the same principles and motivation behind, flight-readiness 
status in aerospace terms is not clearly comparable “on a direct one-to-one 
basis” to the medical device sector, but the eleven criteria provided on the 
previous paragraph define “the care-before-use philosophy of quality 
assurance”. The same philosophy translated to “concrete well-planned control 
activity is obviously needed in equipment for use on human patients” (Lalli et al, 
1972). 
According to the author, the second part of the quality assurance tasks is 
testing the product according to the following subdivisions (Lalli et al., 1972): 
- Inspection 
- Acceptance 
- Operational 
During the inspection, the elements that are embarked are checked ensuring 
that all components are manufactured to the specifications and identifying 
critical parameters. In order to carry out these activities, skilled and experienced 
personnel, and extensive training, are required (Lalli et al., 1972) 
In addition to inspection, the reliance on the manufacturer’s inspection is not 
enough to ensure product performance and acceptance tests are required to 
help on the assurance of the performance (Lalli et al., 1972) 
Finally, after passing the acceptance tests, components are assembled into the 
final product and final tests are run. This integral testing provides the 
opportunity to fully assess the operation of the final product under the 
environmental conditions and expected operational modes (Lalli et al., 1972) 
39 
 
Finally, the conclusions of this paper provide some advices relating to the 
validation process methodology and lessons learned from space projects. “The 
methodology must be prevented from generating a paper blizzard” (Lalli et al., 
1972). As the author highlights, it is critical to keep the paperwork simple and 
“encourage simple language and forms”. It is important to point out the fact that 
“paper cannot replace sound simple engineering evaluation and judgement”. 
However, the author warns that “improving the methodology does serve to 
reduce the frequency of human or material failures, but obviously it will not 
completely eliminate them” (Lalli et al., 1972). 
In the end, a final recommendation from the author (Lalli et al, 1972) it is 
exposed which clearly fits with what other regulatory authorities (FDA, 2011, 
Long, 2011) has stated later on its industry guidelines: it is essential to monitor 
and control the manufacturing and test processes and to maintain close 
adherence to specifications, parts must be standardised as much as possible 
and good housekeeping practices must be followed at all times and places. The 
system can be costly, but it can save much more (Lalli et al., 1972) 
2.5.  RESEARCH GAP 
Despite several relationships and links between the aerospace and the medical 
sector have been found within the literature review, some knowledge gaps and 
improvement areas have been identified: 
- There is no specific information regarding which specific practices and 
procedures require to be developed for addressing effectively the 
validation stage. 
- There are no analysis related to the resource infrastructure and 
investment required for developing a fully reliable and efficient process 
validation phase. 
This research project aims to address these knowledge gaps by identifying the 
best validation practices within aerospace sector and provide the required 
procedures and resources for their translation and implementation within a 
medical device manufacturing organisation. 
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2.6.  SUMMARY 
In this literature review chapter the key elements, terms and concepts that the 
research thesis will cover have been introduced. It has been demonstrated that 
the benchmarking process is considered as an improvement tool for the 
organisations and its structured approach and stages have been outlined. In 
addition to this, the regulatory framework of the project has been introduced 
with the presentation of the validation concept and how the different sectors 
(aerospace and medical) cover it, and providing particular details on the 
“process validation” practices and the role of quality assurance along this stage. 
Consequently, a link between these two sectors has been established and 
finally, the research gaps on the literature have been identified. 
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3. RESEARCH METHODOLOGY 
This chapter describes the methods and techniques used to conduct this 
research project, giving a general overview of the approach to this study. 
The research approach for this project can be defined as a qualitative study and 
the author used several research tools, techniques and activities during this 
period. 
An essential part of the study was to assist the company’s Quality Assurance 
department to perform the process validation for 2 different medical devices. 
This also included the implementation of new techniques which were chosen 
together with the company’s management board.  
3.1.  APPROACH 
As it has been shown on the Literature Review chapter, when facing a 
benchmarking process, several approach and study methodologies can be 
adopted. Depending on the author, this process may be composed by a 
different number of stages. 
The selected approach, despite sharing the main philosophy of the 
benchmarking processes proposed by the literature, does not follow any of 
them in particular.  
 
Figure 3.1. Research approach. 
At first glance, it can be appreciated that two of the three process boxes are 
located on the “Medical Device” side. This implies that the main activities and 
ImplementEvaluate
Learn
Aerospace
Medical Device
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“driving force” of this research will be focused on evaluating and developing the 
procedures of JEB, leaving the other process as an information source and 
improvement tool. 
• Evaluate: The first step will consist in realising Where we are, Where we 
want to go and How are we going to achieve our destination. As a result 
of this stage, the key parameters and specific improvement areas will be 
obtained. 
• Learn: This word represents the core and end-objective of the 
benchmarking study; to identify and learn the best practices that players 
from a different industry sector are using for solving the common-nature 
problem. 
• Implement: The meaning that relies behind this word is related to a pro-
active attitude. Once the previous phases have been successfully 
completed, it is time to get into action and apply all the outcomes 
obtained in the previous stages. 
Basing on these three principles, in the following lines a more specific and 
detailed guideline of the project’s programme is given, describing the main 
activities and results of each stage. 
3.2.  RESEARCH PHASES 
The Figure 3.2 illustrates the structure of the research methodology selected for 
this research project. 
43 
 
 
Figure 3.2. Research Project Phases 
3.2.1.  Phase I: JEB internal analysis 
Due to the characteristics of the required information, a qualitative analysis was 
performed on the current practices, challenges and problems that the company 
was facing during the process validation phase. This analysis was based on 
semi-structured interviews with the relevant personnel (designers, engineers, 
managers, customers) involved in these activities and the author’s field 
experience during this stage. These interviews were designed to capture 
information and workers opinion relevant to the different activities during 
process validation, including their role’s responsibilities, critical milestones or 
the resources available for performing the different tasks. In addition to this, the 
company internal quality procedures, standards and resources allocated for 
process validation have been reviewed with the objective of ensuring that the 
newly developed procedures are totally integrated within the practices of the 
organisation. 
3.2.2.  Phase II: Cross-industry benchmarking study 
In order to capture the leading practices related to the validation stage, a 
benchmarking study was undertaken within the aerospace sector. This study 
was carried out through several techniques and sources, including an extensive 
PHASE I
PHASE II
PHASE III
PHASE IV
Cross-Industry Benchmarking
Implementation & Monitoring
JEB Internal process analysis
• Analysis of current status
• Characterization of organisation 
and validation activities.
• Identification of improvement 
required tasks and procedures.
• Literature Review
• Elaboration of questionnaire
• Selection of participants.
• Benchmarking campaign.
• New procedures deployment and 
implementation
• Corrections and/or further 
improvements proposal
Results Analysis & Proposal
• Data gathering
• Results analysis
• Proposals
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literature review, the consultation of benchmarking databases, corporate 
websites and publications, and seven direct, semi-structured interviews. The 
questionnaire and interviews were based and developed in order to capture the 
information related to the main improvement areas identified on the internal 
analysis. 
3.2.3.  Phase III: Best practices analysis and proposal 
At this stage of the study, a qualitative analysis was done on the outcomes and 
findings of the benchmarking study. Based on the information gathered on this 
study and taking into account the improvement requirements detected on Phase 
I; a list with the new practices proposal was created and validated by panel of 
experts. 
3.2.4.  Phase IV: Implementation and monitoring 
In this phase, the new practices implementation guidelines were provided in 
order to integrate the identified best practices within the medical device 
manufacturing company. The opinions and recommendations from the previous 
experts’ panel, the expected benefits, complexity and resource requirements of 
the new procedures were considered for generating these guidelines. 
3.3.  SUMMARY 
This chapter has introduced the research methodology followed for this project. 
Based on an Evaluate-Learn-Implement approach, a four-phased methodology 
has been developed for achieving the aim and objectives of this study. The 
activities of the first phase are focused on identifying the improvement areas of 
the organisation, the leading practices of the aerospace sector are evaluated 
through the benchmarking campaign of the second phase, resulting in a list of 
proposals, once they have been analysed and validated, and concluding with 
the new procedures implementation guidelines. 
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4. COMPANY INTERNAL ANALYSIS 
This chapter describes the internal evaluation of the current validation process 
and activities of the company. For the purpose of this study, a total 
understanding of the business processes and validation procedures was 
required. 
During the research period, the author was based at the company premises 
collaborating closely with the Quality Assurance Department, the area 
responsible for medical manufacturing process validation, and working on the 
validation process of several surgical device projects. 
4.1.  DATA COLLECTION 
Sources of information: 
1. JEB Quality Management System procedures 
2. Semi-structured interviews with company employees 
3. Author’s day-to-day work experience in medical validation 
4.1.1.  Company Quality Management System procedures 
As a first contact and in order to familiarise with the validation process and other 
related procedures, the company’s Quality Management System was reviewed 
to get a clear picture of the activity logics. JEB is certified in ISO 9001:2008 
Quality Management and ISO 13485:2003 Medical Device Quality Management 
Systems. 
4.1.2.  Interviews 
Another valuable source of information for drawing the current status of the 
company was the several semi-structured interviews carried out through the 
whole research period. 
In order to conduct these interviews, a questionnaire for the organisations 
internal analysis (Appendix A) was used. The structure of this questionnaire 
was: 
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- General Information 
- Process validation 
- Resources 
The first part of the interviews contained general information questions relevant 
to the role within the company, years of experience and key functions and 
responsibilities in the department. 
The second part was focused on the specific tasks and activities during the 
medical device process validation stage. Opinions regarding the procedures, 
workflow, performances and involvement of the interviewee during this stage 
were asked. 
Finally, the last part of the questionnaire included questions related to the 
allocation of resources and any further resource requirements and 
considerations associated to this particular stage. 
In order to validate the capacity of the questionnaire in capturing the desired 
information, 3 sample interviews were made with the operators involved in the 
medical section, for testing purposes. The outcomes of the test proved its total 
suitability and success in gathering the desired information. 
A total of 10 employees from different departments and positions within the 
company were interviewed, as it is summarised in the following table: 
 
Table 4.1. Internal Analysis interviewees 
Area Role
Management - Managing Director- Production Manager
Quality Assurance - Quality Assurance Manager- Quality Assurance Engineer
Production / 
Manufacturing
- Mould shop Manager
- CNC area Manager
- Manufacturing area assistant 
- Tool room operator
- Test operator
IT department - IT Department Manager
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4.1.3.  Work experience 
Finally, the author, as a member of the Quality Assurance Department, has 
been involved in the several tasks and activities related to the development of 
two new designs of surgical devices, the definition and update of quality 
procedures and the assessment of best resource allocation, acquiring useful 
and first-hand information. 
The experience accumulated during this time period includes: 
- Drafting and generation of validation related documentation 
- Carry out protocols and reporting 
- Samples data collection & testing 
- Technical documentation research 
- Feedback from OEM and customers 
- QMS procedures update 
 
Figure 4.1. Process Validation Flow Chart (FDA, 1987) 
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4.2.  DATA ANALYSIS 
A qualitative analysis was performed once that the relevant information has 
been collected and classified, as it can be summarised on the following 
flowchart. 
 
Figure 4.2. Internal Data Analysis 
This analysis was focused on evaluating the current status and comparing it to 
the desirable one, identifying the improvement areas and always taking into 
account those aspect of the process in which a poor level of performance would 
affect  the following elements: 
- Product quality 
- Product reliability 
- Product traceability 
- Time 
- Costs 
- Installations and equipment 
- Customer’s satisfaction 
In order to perform this analysis, several constraints related to the process 
validation particularities, customer requirements and available resources were 
considered. Finally, relevant workers and players provided opinions and 
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feedback along the process and the outcomes of the analysis were validated by 
a panel of experts. 
4.3.  RESULTS 
In this part of this chapter, the results and findings of JEB Internal Analysis are 
described. Due to the characteristics and similarities shared by these results, it 
has been decided to separate and differentiate the outcomes of the internal 
assessment according to their nature and 2 categories have been established, 
procedural related improvement and resource requirements.: 
 
Figure 4.3. Problem and issues classification 
- (P)Procedures: issues related with the work flow in place, instructions 
and orders that may affect to the overall performance of the process 
validation. 
- (R) Resources: problems related with the lack or non-efficient 
assignation and distribution of resources (i.e., human resources, time, 
material, equipment) at each stage of the process validation.   
INTERNAL ANALYSIS
Information sources
QMSWork Experience Interviews
RESULTS
Performance issues & improvable areas
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R.)
Resources
P1. Documentation
P2. Risk Assessment
P3. Communication
P4. Identification
P1. ERP
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4.3.1.  Documentation management 
This has been identified as a critical point within the validation stage. As it is 
requested by the Regulatory Authorities, in this particular case the FDA, all 
medical companies are required to maintain a secure, comprehensive and 
centralised system to manage all quality procedures, product documentation 
and manufacturing procedures, as well as tracking all the changes made (FDA, 
2008). In addition to this, it is also expected that the documentation 
management system is capable of identifying all the documents impacted by 
quality events and product changes. 
Validation Protocols and Reports are fully generated on a word processor (MS 
Word) file. The validation related documentation contains several attachments 
which may be presented in different file formats (images, pdf’s, CAD drawings, 
etc.). The integration of these files into a unique document results in a non-
efficient and time-consuming process. 
Considerable amount of time is dedicated to deal with an inadequately 
structured and configured validation documentation system. This time is non-
productive, as the activities required to manage and sort out these database are 
not value-adding and do not contribute to the overall success of the process 
validation. 
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Figure 4.4. Document structure 
In addition, documents are not correctly structured and configured, they do not 
exploit all the advantages of documentation software, making more difficult and 
tedious the protocol and report drafting process.  
Finally, some difficulties have been found with the distribution and revision 
control of documents and drawings that should be solved to avoid possible 
future non-conformances.  
4.3.2.  Risk assessment 
A risk assessment analysis (pFMEA) is one of the customer’s requirement prior 
to the completion of the PQ. 
Although this activity is currently covered by the company procedures, the 
actual process does not follow the provided guidelines; resulting in considerable 
deviations and approval issues, delaying the final stage of the validation and 
acting as a bottle-neck. 
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Figure 4.5. pFMEA – OQ Transition 
4.3.3.  Communication 
Communication methods and procedures need to be developed within the 
company. It has been observed that some orders and requests procedures 
(production runs, test activities, calibration, engineering change requests, etc.) 
are not totally effective, resulting in unnecessary delays and potential causes of 
confusion and errors. 
It has been also detected that there is a communication disconnection between 
the Quality Assurance Department and other functional areas within the 
organisation, generating an obstacle or barrier. Documentation are not in a 
standardised format, wording or either location; resulting in possible difficulties 
in interpreting the commands, not providing or prioritising the appropriate 
resources to resolve quality issues and, consequently, impacting the result of 
the product.  
 
Figure 4.6. Communication scheme 
Communications with the customer is not as fluent and easy as desirable; there 
are no standard procedures in place for validation related documentation and 
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requirement discussion, amendment or review, resulting in some occasions in a 
highly non efficient and confusing activity. 
Communications with the customer are mainly managed by e-mail and 
conference calls. In addition to this, at the present there is a limitation with the 
size of the file and documents that can be sent enclosed in the messages. 
Despite not being a current major issue, validation related document file-size is 
constantly increasing and this may become a major problem in the future. 
4.3.4.  Identification and traceability 
Despite not recording any major issues or non-conformances, it is has been 
suggested by the customer and external audits that the tool and calibration 
databases, component identification and traceability (parts, raw material, tooling, 
etc.) should be improved. 
Procedures developed in this field will be focused to meet the requirements 
provided by the FDA, which states that medical device manufacturing 
companies shall maintain a system to track all materials and associated 
suppliers used in production, in order to ensure the quality of the final product. 
(FDA, 2008) 
In addition to this, a current objective of the organisation is to step forward and 
implement a barcode or RFID technology based solution. A case-study and 
implementation feasibility analysis is suggested to be performed before taking 
any further decision. 
4.3.5.  ERP software 
Although there is an Enterprise Resource Planning (ERP) system in place in the 
organisation (SYSPRO), it is not fully implemented within all the departments 
and divisions of the company.  
The total implementation feasibility of an ERP solution has been suggested by 
external auditors to be evaluated as an improvement in the IT structure of the 
company.  
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4.3.6.  Personnel 
During some periods of the validation process, a considerable amount of 
activities are accumulated, resulting in workload peak-demands that may 
overcome the personnel availability.  
4.3.7.  Training 
Training in validation related software (i.e., Statistical Process Control Software) 
and other computer skills (e.g. ERP) should be considered for all the personnel 
involved in process validation. 
The training and qualification offer available for the personnel should be 
expanded, as well as the tools and resources related to them: facilities, material, 
offer, trainers, IT network, etc. 
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4.4.  VALIDATION OF RESULTS 
In order to validate the results obtained from the internal analysis, a workshop 
involving several experts and stakeholders across the company responsible for 
the development and manufacturing of medical devices was organised. 
This expert’s panel was composed by: 
- Managing Director 
- Quality Assurance Manager 
- Design leader Engineer 
- IT Manager 
- Test lead operator 
4.5.  SUMMARY 
As a summary for the internal analysis of the sponsor company, the target and 
development expectations are condensed in the following bullet-points: 
- Achieve a highly efficient Documentation Management System and 
reduce the amount of time and work-load spent on non-value-adding 
activities, such as documentation system corrections, amendment and 
control. 
- Develop a reliable validation process monitoring system in order to 
obtain a real-time status of the process, enabling better control of the 
workflow, provide accurate quality information to the decision-makers, 
better resources allocation and gaining transparency. 
- Set up a dynamic communication procedures between the different 
players involved in process validation, focused on assuring the correct 
and efficient information collection and sharing. 
The following table summarises the results of the internal evaluation of the 
company’s process validation current practices performed during the first stage 
of this research project. 
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Table 4.2. Internal Analysis Results: Improvement areas. 
Despite these minor issues; all of them related with resource management, 
performance level and process efficiency; it can be concluded that the overall 
valoration of the current practices in process validation is “Good or Very Good”, 
as stated by current customers and external parties. 
It can be pointed out that no issues were found in relation to the manufacturing 
techniques or test procedures, which would affect the product reliability, 
resulting in serious non-conformances on the process validation and major 
complains from the customer. 
  
PERFORMANCES
P1 Documentation
P2 Risk Assessment
P3 Communication
P4 Identification
RESOURCES
R1 ERP
R2 Personnel
R3 Training
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5. BENCHMARKING STUDY 
5.1.  INTRODUCTION 
This chapter describes how the benchmarking study for the identification of the 
best practices within the aerospace sector relating to process validation was 
performed. 
First of all, this section establishes the partner selection criteria, which was 
based on the considerations defined during the definition of the research scope. 
Then, it details the data collection methods used and its different sources. Once 
the information was collected, the analysis of the findings and outcomes of the 
study was performed, resulting finally in a set of practices that were proposed to 
the company for their implementation within the organisation procedures. 
However, prior to this integration step, the set of proposals were evaluated and 
validated by a panel of experts based on the knowledge of the internal 
procedures of the company, industry and work experience. 
5.2.  COLLABORATORS SELECTION 
As defined in the scope of this research project, this benchmarking study will 
consist in a cross-industry evaluation which will focus on capturing the leading 
practices within the aerospace sector regarding the process validation activities. 
In Figure 5.1, it can be appreciated a concise scheme that illustrates the 
abovementioned criteria. 
 
Figure 5.1. Desired information capture framework 
Aerospace Industry
Europe
UK
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In first place, the study boundaries for the collaborators were set within the UK 
aerospace and defence manufacturing industry. However, by following the 
benchmarking literature review, which states that it is not always possible to 
obtain the desired information within a predefined and immobile area (Zairi, 
1996; Codling, 1992), these limits required to be widened and other aerospace 
organisations in the European Union were considered. It was decided that if 
only limited information could be gathered from the previous range, 
collaborators scope limits could be opened again and any aerospace industry 
company across the world could be considered for the purposes of the 
benchmarking study. Finally, in a last iteration, in the eventual case that no 
information at all could be gathered, other close-related industries would be 
considered. 
5.3.  DATA CAPTURE 
Once the collaborators selection criteria was established, the next step of the 
benchmarking study consisted of defining the best data collection methods 
according to the purposes of this research project. 
Prior to the introduction of the different information capture methods, the 
characteristics and nature of the data that this research project required was 
evaluated. Owing to the particularity of the study, focused on learning the 
leading practices from a sector (aerospace) and translating them into a 
company which operates in another one (medical device) (Camp, 1998), it was 
concluded that the qualitative approach would be the one that fitted the best for 
the purposes of this project. 
In contrast with quantitative research methods, which are focused on the 
elements that can be measured and directly compared, qualitative methods 
involve subjective and opinion driven information, where observations are 
tested in order to derive a conclusion and build a solution (Rolstadas, 1996). 
Different data capturing tools and methods were developed focused on 
gathering qualitative type information. 
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Figure 5.2 illustrates, with the same idea-behind as previously showed in the 
Literature Review section, in a pyramid-shaped diagram, the different 
benchmarking data collection methods and their valuation according to two 
different criteria; the resource and investment requirements to perform the study 
and the value and relevance of the information that could be obtained through 
them. 
 
Figure 5.2. Information capture methods (Andersen and Pettersen, 1996) 
Due to the characteristics of the information that was being sought, the 
particularities of the research project, the time and resource constraints and 
other external factors, such as the availability or willingness of the potential 
collaborators to take part in the study; not all of these methods were used by 
the author for the purposes of this research. Particularly, only the public 
available resources and live interviews were considered. 
5.3.1.  Publicly available information 
The data collection methods used for this research that can be classified into 
this segment are: 
- Literature: books, journals, papers, articles, specialised magazines, etc. 
- Conference papers and presentations 
- On-line Benchmarking Best Practices databases 
- Professional association websites and forums 
- Corporative brochures and websites 
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- Technical reports 
5.3.2.  Interviews 
A series of live interviews with different participants from the aerospace sector 
were undertaken for this research project. These collaborators were chosen 
according to different criteria such as their role within the organisation, years of 
experience, business activities of the company, level of involvement within 
process validation activities, willingness to take part in the study and their 
availability. 
A first contact was made via e-mail and/or telephone in order to set up an 
upcoming meeting, live conference call or on-site visit, whenever this was 
possible. 
Due to the characteristics of the information given, involving organisation 
internal procedures and details, for the benefit of confidentiality, none of the 
participants and/or the respective companies involved in these interviews are 
named. The following table provides a brief description of each of the 
participants. 
 
Table 5.1. Benchmarking Interview Participants 
The benchmarking interviews were conducted using a semi-structured 
questionnaire (see Appendix II), which can be classified into three main 
information areas: 
- Introduction 
Company Area Activity Role Years ofexperience
A UK Aerospace 1st Tier supplier. Design Team Leader 14
B UK Aviation Maintenance Services Quality Assurance Engineer 10
C Europe OEM Quality Assurance Engineer 8
D Europe OEM Manufacturing Engineer 6
E Europe
Aeronautical 1st Tier supplier 
and Consulting Services 
provider
Consultant Engineer
(Structural design 
department)
6
F Europe Technology ConsultingCompany (Aerospace)
Consultant Engineer
(Product life-cycle) 7
G World Technology Consulting company(General)
Consultant Engineer
(Technological risks) 4
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- Process Validation 
- Resources. 
The introduction part encompassed general information questions aimed at 
capturing broad information about the participant and his role and 
responsibilities in the organisation. 
The process validation part focused on the practices and procedures employed 
by the interviewee and his/her organisation in the achievement of the different 
requirements and deliverables within the validation stage. Questions involving 
the main difficulties found along the validation stage or the human resources, 
such as team organisation and role assigning for the activities of this phase 
were also included. 
Finally, the last part of the questionnaire was intended to provide a general idea 
of the different means, tools and resources available for performing the prior 
activities. 
5.4.  KEY FINDINGS 
Information was collected and documented conveniently, building a consistent 
knowledge database. 
The Table 5.2 summarises the results and key findings of the benchmarking 
study and provides an overall opinion of the sources and the quality of the data 
gathered for each of the information areas defined at the Internal Analysis stage. 
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Table 5.2. Benchmarking Study Summary Table 
At first glance, it can be appreciated that where a method resulted to be “weak” 
in obtaining the desired information in a specific area, this was properly covered 
by another one, resulting in a successful combination of data gathering methods 
Going further on, it can also be pointed out the fact that, although being defined 
as a highly helpful and accurate information capturing method, live interviews 
could not provide useful (and usable) data in some areas which can be 
considered as “delicate” regarding the privacy and confidentiality of the 
information, involving organisation’s internal procedures, capacities and 
resources. 
It should also be highlighted the important role of the publicly available 
information, which provided good quantities of useful data for the purposes of 
this study and filled up those areas where live interviews did not provide any 
sort of information. 
Finally, as the green arrows indicate in the abovementioned table, there were 
some cases that, despite the amount of detailed data provided, due to the 
particularities of the company or its business environment (size, budget, project 
characteristics, special regulations, etc.) and the impossibility of translating any 
Methods
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Risk Comm. Id. ERP Staff Train.
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of these conditions; the information resulted not very useful for the purposes 
and the scope of this research project. 
On Table 5.3, the main outcomes of the benchmarking study are outlined. 
 
BENCHMARKING STUDY RESULTS 
Reference Outcome 
P1: Documentation Management 
P1.1 
- Independent modules 
The different elements/entities that compose one document are 
created separately and they shall be treated as independent to each 
other. 
The final and definitive document file is then assembled and created 
when all the sections are completed. 
P1.2 
- PDF role in the process 
The PDF type file acquires more relevance within the documentation 
workflow, not only for final deliverable documents, but on a daily work 
basis. 
PDF editor software is crucial for a good management of these 
resources. 
P1.3 
- Interactive Masterlists 
In the organisations with no ERP implemented in the evaluated 
departments, documentation masterlists are widely used in order to 
keep organised all the relevant files.  
As a value-adding feature to this, according to the consulted literature 
review, references and hyperlinks are utilised with time saving and 
organisational purposes (Garretson et al., 2005). 
This method has been proved to be very helpful as well when large 
revisions of the documentation systems are carried out or quality 
audits are undertaken. 
P1.4 
- Documentation Management System (DMS) 
Four out of seven of the participants interviewed showed that within 
the organisation a DMS module as an add-on of their ERP was in 
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BENCHMARKING STUDY RESULTS 
Reference Outcome 
place for the generation, editing and management of all the relevant 
documentation. By working this way, the time spent in documentation 
administration related tasks are taken off the user and avoiding non-
value adding activities. 
P2: Risk Assessment 
P2.1 
- Use of FMEA  
All the participants confirmed that this risk assessment tool was 
widely used at some stage during the validation phase of a new 
design, resulting in a helpful method for detecting possible errors, 
failures and risks. 
It also encourages the creation of a teamwork environment where 
different roles and position involved in the project gather together to 
discuss the possible setbacks on the product development flow. 
However, little or no further procedure related details could be 
obtained through these interviews. 
P2.2 
- FMEA scoring criteria 
When recurring to the publicly available resources, the literature 
review performed for this research permitted to compare the sponsor 
company’s current FMEA scoring criteria to other organisations in the 
aerospace industry. 
Moving within the same similarities area, where direct comparisons 
could be attempted to be done, these proved that the current criteria 
in place is aligned to the best-in-class practices of the aerospace and 
defence industry. 
 
P2.3 
- FMEA Documentation/Templates 
In a parallel way to the comparison of the scoring criteria, templates 
from the available literature review were evaluated. These 
comparisons showed that despite some minor modifications, a 
common structure and functionality is shared with the ones 
recommended by the consulted authors. 
Effective documentation provides the outcomes of the FMEA 
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BENCHMARKING STUDY RESULTS 
Reference Outcome 
traceability of the evaluated requirements during the manufacturing 
process; allowing the quality management department to trace 
eventual problems effectively and mitigate the identified risks. 
P2.4 
- FMEA procedures 
No practical details for the FMEA procedures were obtained from the 
live interviews with any of the participants. 
The sponsor company’s FMEA framework was compared to other 
procedures available in the literature. 
It was found that some variations in the pre and post analysis 
meetings, as well as the resources (time, software, teams) invested in 
this process may lead to sound improvements in the current work 
flow. 
In particular, it needs to be highlighted the figure of the “Analysis 
Conductor” or “Facilitator”, who is identified as the responsible of 
managing the process and enhancing the effectiveness of the 
analysis. This role shall exceed in organisation, participation 
encouragement and discussion management skills (Dyadem, 2003) 
P2.5 
- FMEA software 
As a result from the interviews, in three of the organisations consulted 
dedicated software for the FMEA stage is used and widely extended, 
resulting in a dynamic and user-friendly process where participants 
are able to concentrate in the analysis rather than in the 
documentation generation. 
In the other four, according to the interviewees, due to the 
characteristics of their projects, the number of analysis required for 
the process and the extension of these; a standard MS Excel based 
spread-sheet template proved to be sufficient for their purposes. 
 
P3: Communication 
P3.1 
- On-line Video-conference calls 
Four out of the seven consulted participants, when meetings or 
conference calls are required with external branches of the 
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BENCHMARKING STUDY RESULTS 
Reference Outcome 
organisation or customers, in order to deal with major updates, 
changes or critical reunions are required to be held; on-line live video-
conference calls are set up for these purposes. Taking advantage of 
the current status of software, hardware resources and internet 
connection properties, several service providers and platforms are 
available for hosting these events. It is commonly agreed that these 
have been resulted in increased efficiency, time saving, constructive 
and positive experiences. 
P3.2 
- Review Stages 
Down the workflow of the documentation draft and generation 
process, several review stages are established prior to the approval 
release (BMP: CoE website, Lockheed Martin; Hasson et al., 1997). 
In these reviews, different parts of the department responsible for the 
document generation are involved in with the objective of assuring 
the accuracy, error-free, quality and correction of the documents 
produced. 
P3.3 
- “In-cloud” services 
It is considered as a new data and information sharing method as a 
reliable alternative to the common ones based on Intranet server 
based services. 
P4: Identification and traceability 
P4.1 
- Shop floor data collection 
Five out of seven participants stated that shop floor data collection 
methods were widely used across their organisation, being the job 
cards or variations of this concept the most common method. 
Particular procedures and examples for these data collection method 
are also covered by the extensive literature review performed (Watts, 
2008). 
P4.2 
- Bar-codes 
As a main input method for the abovementioned shop floor data 
collection method, bar-coded systems was used by all the 
organisations of the interviewees. 
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BENCHMARKING STUDY RESULTS 
Reference Outcome 
Benefits resulting from bar-code implementation include the 
elimination of operator key strokes, elimination of record-keeping 
errors, improved work environment, reduced cycle time/efficiency 
(Raytheon, 2005) 
P4.3 
- RFID technology 
RFID technology allows information to be stored in tags that are 
attached to components providing the opportunity to transform the 
mean that data related to products and equipment is gathered and 
analysed in real-time. 
Within the four companies that are directly involved in manufacturing 
and maintenance activities, keeping track and located the vast array 
of specific tooling and jigs in their facilities represents a big challenge. 
When performing a 100% tool check manually is non-feasible, 
automatic identification technology based in RFID was concluded as 
the best solution. 
R1: ERP 
R1.1 
- Total Implementation 
All the participants of the interviews assured that an ERP solution 
was implemented within their organisations. In addition to this, total 
implementation was an actual fact within all the departments related 
to validation processes (manufacturing, production, quality 
assurance, procurement) 
According to the collaborators and the literature review (Parry et al., 
2003), the main benefits from ERP total implementation are having a 
greater control and visibility of the manufacturing related activities, 
real-time access to accurate data, improved forecast, better 
resources allocation and cost management 
R2: Personnel 
 
- Human resources 
Depending on the characteristics of the organisation analysed and/or 
interviewed, a diverse range of answers were obtained regarding the 
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BENCHMARKING STUDY RESULTS 
Reference Outcome 
availability and distribution of human resources, the assignation of 
responsibilities and the specific tasks and activities of the 
departments and roles involved in process validation. 
R3: Training 
R3.1 
- Training catalogue 
All of the organisations have implemented a training catalogue where 
different courses, trainings and workshops are offered to their 
employees, which are able to consider and select the appropriate one 
according to a set of specific factors, such as their level, skills or shift 
availability. 
In addition to this, it has been regarded the importance of the role of 
the trainer, being motivation and communication skills critical for an 
appropriate connect and knowledge transmission. 
R3.2 
- On-line training resources 
Two of the organisations have incorporated on-line corporative tools 
for personnel development. This way, the responsibility of skills and 
capacities development is transferred to the own individuals. The e-
learning framework and catalogue is available on the corporate 
intranet, where employees can access to their specific set of skills 
and select the desired training course. 
Table 5.3. Benchmarking Study Results 
Regarding the development area R2: Personnel, it requires to be highlighted 
that it resulted unsatisfactory and no relevant results were obtained from the 
benchmarking study and the posterior analysis due to a various set of reasons, 
including the differences in relation to the size of the companies interviewed and 
the sponsor company, the functional structure and the particular characteristics 
of the projects.  
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5.5.  DATA ANALYSIS AND PROPOSALS 
The stage that follows the information collection and documenting is the 
analysis of the outcomes of the study; which is focused on obtaining, from this 
outputs list, a set of elements and practices that could be successfully 
translated to the sponsor company own procedures. 
For this exercise, two different sets of factors have to be taken into account: 
1. Implementation feasibility and benefits expected. 
2. Organisation internal factors. 
In the first group, the following information, perspectives and criteria have been 
considered for this analysis: 
- Consulted literature review 
- Reports and previous area related publications 
- Participants professional experience 
On the other hand, regarding the factors associated to the organisation, a totally 
different group of parameters had to be considered: 
- Time and material resources available 
- Engineers, operators and other employees’ implication 
- Management level commitment 
- Customer requirements and expectations 
- Regulatory authorities’ compliances. 
As a result of this, a set of scores related to the benefits expected from the 
implementation and its complexity (defined as the amount of effort required or 
type of resource needed) have been established in order to evaluate each of 
the outcomes of the benchmarking study. On Table 5.4 the results of the 
assessment are summarised. 
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BENCHMARKING RESULTS ANALYSIS 
 Ref. Finding Benefit Complexity 
P1 
Documentation 
P1.1 Independent modules 4 1 
P1.2 PDF role in process 4 2 
P1.3 Interactive masterlists 4 2 
P1.4 DMS 4 4 
P2 
Risk 
Assessment 
P2.1 Use of FMEA - - 
P2.2 FMEA scoring criteria - - 
P2.3 FMEA Documentation/Templates 5 1 
P2.4 FMEA procedures 4 2 
P2.5 FMEA software 2 4 
P3 
Communication 
P3.1 On-line Conference calls 3 2 
P3.2 Review stages 5 2 
P3.3 In-cloud services 4 2 
P4 
Identification 
P4.1 Shop Floor Data Collection 5 3 
P4.2 Bar-codes 4 4 
P4.3 RFID technology 1 5 
R1 
ERP 
R1.1 ERP Total implementation 2 5 
R3 
Training 
R3.1 Training catalogue 4 3 
R3.2 On-line Training resources 4 5 
(Benefit 1=Low, 5=High; Complexity 1=Low, 5=High) 
 
Table 5.4. Benchmarking outcomes analysis 
A first conclusion that can be withdrawn from this matrix is what it is called as 
the “instant winners”, those practices which share a green-green shade on their 
valoration columns: by their integration, a wide range of benefits are expected 
with a little resource and effort investment required. 
5.5.1.  Documentation Management 
As it can be appreciated on the previous matrix, results related to this area were 
found within the extensive literature review, corporate website visits and live 
interviews, being the later the one which provided the most useful resources for 
the purposes of this project. 
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Regarding the documentation management practices, all the entities analysed 
share the philosophy of keeping a clear, structured and user-friendly 
documentation system in order to provide a powerful tool for all the reporting 
and information generation related activities. 
As a common characteristic of all the organisations within the aerospace 
company, documentation management (protocols, technical reports, drawings) 
plays a critical role in keeping ordered and updated all the documented 
evidences involved in the development of a product. 
An efficient process validation revolves around a structured and well-based 
documentation system, owing to the fact that these files will give evidence of 
meeting all the requirements given by the customer and regulation authorities, 
being these elements the one which would be reviewed if any issues are raised 
during the lifecycle of a new product. 
The main proposals for this area are summarised in the following bullet-points: 
- New documentation structure; commencing with process validation 
related files and progressively implementing across other departments 
and functional areas of the organisation. 
- Masterlists with hyperlinks 
- Update / Procurement of documentation edition and management 
software 
- Quality control Database: review and update QMS documentation 
procedures. Documentation revision control. QMS should be published 
electronically on the intranet for accessible consulting. 
In order to comply with possible future regulations, the documentation system 
should be provided with controls to ensure integrity, accuracy and reliability of 
the information, especially the documented evidences related to process 
validation. Moreover, the system shall provide some type of audit trail to prevent 
and detect un-authorised creation, addition, alteration or deletion or records.  
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5.5.2.  Risk Assessment 
The interviews proved what the literature review had previously stated, the fact 
that the Failure Modes and Effects Analysis (FMEA) is a practice widely 
implemented within aerospace companies and owing to its success it has been 
gradually adopted by other sectors, such as the medical device industry. 
Following the guidelines provided by the literature review, a new template for 
the FMEA analysis is proposed in order to capture all the information required, 
provide more dynamism to the evaluations and enhance the achievement of 
results.  
In addition to this, the sponsor company’s procedures relating to this risk 
assessment process should be considered to be updated and the figure of the 
Facilitator or Champion introduced. 
 
Figure 5.3. FMEA Analysis Panel (Northrop Grumman, 2012) 
5.5.3.  Communication 
With the aim of improving the communication framework within the sponsor 
organisation, from the outcomes of the benchmarking study two different fronts 
were identified for this purpose: 
1. Procedures review, gap analysis, improvement opportunities and update 
2. Resources allocation 
Procedures updates proposed include: 
FMEA Core Team
(4-6 Members)
Expertise in Product/Process
Cross Functional
Communication
Positive attitude
Participation
Champion / Sponsor
Resources & Support
Promotes team effort
Initiative
Implementation Leading
Recorder
Documentation
Coordinate meetings
Team Leader
Leadership skills
Maintain and promote 
participation
Lead Engineer/Project Leader
Facilitator
FMEA expert / Process Leader
Encourage & develops team 
dynamics
Communication skills
Encourages participation
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- Team meetings and panel analysis review prior to critical points in the 
schedule, non-conformances or any major changes to the product. 
- Additional review stages prior to the release of any documentation. 
- Regular (weekly) Project status review meetings at critical stages of the 
schedule, major deliverables, high concentration of activities. 
- Regular (weekly, monthly) advisory circulars with project status, 
summary, upcoming events, etc. 
- Quality Management System manual, procedures, instructions made 
more accessible to the employees. 
Resources: 
- Web based “in-the-cloud” information sharing applications 
- Video-conference calls technology 
- Quality Management System Intranet 
 
5.5.4.  Identification and traceability 
In terms of improving the identification and traceability aspects, the first 
milestone should be the implementation of shop floor data collection methods to 
capture the different parameters involved in the process, which would provide, 
on one hand, a more accurate image of the manufacturing workflow and 
efficiency indicators, and on the other hand, it would meet the FDA 
requirements for full-traceability system, providing information from way back 
through the production process, including operator, machine, lot, material batch, 
inspection reports or raw material supplier. 
A shop data collection method enables information from the factory floor to be 
collected and collated electronically. As each operation or activity is performed, 
the relevant information is captured by the operator.  
- Estimated times for jobs and operations 
- Quality tolerances 
- Labour and quantity costing 
- Automatic job receipt, material issue, lot and serial number entry 
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- Real time information and validations 
A step further on the development of the shop floor data collection methods, 
considering a mid-term scenario, would be the implementation of a bar-code 
based system, which would enhanced the data capturing capacities by reducing 
cycle times, increasing operator’s efficiency and avoiding mistakes originated by 
hand-writing. 
The higher costs comparing to bar-coding solutions, the need to re-structuring 
and re-engineering the process, and above all, the current characteristics of the 
sponsor company’s manufactured devices, lead to consider RFID systems as a 
non-feasible solution, at present. 
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5.5.5.  ERP 
The total implementation of an ERP solution within the company would assist in 
centralising all current systems into one database within the network, providing 
the ability to manage almost all the department key activities. 
Particularly, the area concerning the process validation, the Quality Assurance 
module, would allow to define procedures, tests, audits than can be triggered 
directly within the system, capturing and processing the specific data. In 
addition to this, it will also contribute to the system full traceability, enabling the 
automation of looking back through production (machines, operators, inspection 
reports, raw material supply, etc.) activities; instead of the current hand-
operated and time consuming tasks. 
However, during the analysis stage, it has been concluded that the cost 
involved in implementing the ERP solution into the Quality Assurance 
department, responsible for process validation activities; plus the costs related 
to the personnel training and module development required to replace the 
current system would be huge. As a result, the total implementation of the ERP 
across the department is discarded for the short and medium term. 
5.5.6.  Personnel 
Due to the particularities of this resource area, unsatisfactory and no relevant 
results were obtained from the benchmarking study and the posterior analysis. 
The reasons that lead to this outcome included the differences in relation to the 
size of the companies interviewed and the sponsor company, the functional 
structure and the particular characteristics of the projects. 
5.5.7.  Training 
According to the interviewees, despite the infrastructure, financial resources 
and other elements, the success of an organisation depends finally on the 
capacities of their human resources and their development within the work 
environment. 
This way, training and personnel development are key factors that any company 
must consider when facing new challenges and improving their performances. 
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Back to the literature review, it was previously stated that one of the factors that 
difference between validated and non-validated processes is “Qualified 
Operators” (O’Leary, 2003). 
This highlights the relevance that personnel training (and qualification) plays 
within the process validation. 
Following the analysis, recommendations and results from the benchmarking 
study, a corporate skill development program is proposed to the sponsor 
company, which should cover the essential skills learning, advanced 
developments and corporate culture. 
Currently, regarding the process validation activities, only an ISO 13485:2003 
training course is given by the department. Following the outcomes of the 
benchmarking study, a wider catalogue of workshops, courses and activities are 
proposed: 
- IT skills (General, documentation, Statistical analysis, etc.) 
- Introduction to regulatory framework (FDA, GMP, GHTF, etc.) 
- Risk assessment 
- Quality culture 
5.6.  VALIDATION OF RESULTS 
The objective of this section is to validate the obtained results in the previous 
benchmarking study through a relevant method and looking for its 
implementation within the sponsor company. 
Once the benchmarking study was performed, a continuous process was 
carried out involving several personnel from the sponsor company in order to 
validate the results obtained. 
For the results validation purposes, two different workshops were carried out 
involving a group of experts from different department, roles and management 
levels across the company. 
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As a first step, five key experts were identified for an initial validation of the 
outcomes of this phase. This panel was composed by the Quality Assurance 
department manager, a quality assurance engineer, the production manager, 
the design leader engineer and the IT department manager. Their previous 
experience and opinions created a first opinion for the validation of these 
outputs. It requires to be highlighted that when defining and developing new 
procedures, it is crucial to validate and authenticate the practices with the 
organisation and its employees in order to ensure that the requirements are met 
and no conflicts arise from their implementation. 
For final validation of the results, the principal members of the team involved in 
the medical device process validation stage reviewed its application and the 
different procedures and resources were assessed to ensure agreement. This 
panel included a manager, two engineers from the Quality Assurance 
Department, the medical devices test lead operator, the design engineer and 
the managing director of the organisation. 
This process was done with both management level positions, in order to 
secure integration with the organisations procedures, and also with the specific 
product validation teams and operators, in order to guarantee the usability and 
applicability of the solutions. 
5.7.  SUMMARY 
This chapter has described the benchmarking campaign process, giving an 
overview to the main activities carried out in order to collect the necessary 
information, the analysis of the outcomes and key findings of this study, the 
generation of a proposals list and its final validation by a panel of experts 
composed by members from different departments, roles and management 
levels across the organisation. 
 
  
78 
 
6. IMPLEMENTATION 
6.1.  INTRODUCTION 
Due to the diverse nature of the practices, procedures and solutions resulting 
from the benchmarking study, these elements have highly different set-up 
requirements, both in time and resources, generating a diverse group of actions 
and milestones required for their effective implementation and monitoring within 
the company. 
The effective implementation of new practices and ways of working is not an 
easy road, as demonstrated by previous experiences. From the literature review, 
the following figure depicts the results of a benchmarking study in relation with 
the process improvement within an organisation. From the number of responses 
allocated to each of the reasons, it can be appreciated that the majority of the 
interviewees consider the lack of human resources to implement changes as 
the primary source (Dolan, 2003) of improvement issues, followed by the 
acceptance of results by the departmental managers. 
 
Figure 6.1. Benchmarking Survey: Process Improvement Problems (Dolan, 2003) 
This section, which will assess the implementation feasibility of the proposals, is 
divided into 2 groups: 
- Short term recommendations 
- Long term considerations 
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The first group will be formed by those practices and procedures which will 
provide improvements in a short period of time and are associated to a small 
amount of resource investment requirements. As it has been mentioned before, 
the “instant winners” are classified into this group. 
On the other hand, the long term recommendations are the ones which would 
require higher levels of time, financial or other type of resources, in other words, 
a great commitment from all the parts involved, for their proper implementation; 
or those in which associated benefits and expectations would not be 
appreciated in a short period of time. 
6.2.  SHORT TERMRECOMMENDATIONS 
This section includes the different practices which implementation and 
integration within the company’s procedures are expected to provide the best 
results and improvements on a short term scenario; while a low amount of 
resource investment would be required. 
Due to this, during the research period of this thesis, some of these practices 
have been effectively implemented and monitored, providing useful information 
and proving correct some of the results of this study. 
6.2.1.  Documentation system management 
New documentation generation and management related practices have been 
effectively implemented during this research project period. 
It has been demonstrated that the new framework provides the capacity to 
achieve time reductions of up to 90% in the generation of process validation 
related documentation; by spending little resources in software purchasing and 
training. 
In order to illustrate these new procedures and approaches, Figure 6.2 
describes the new documentation structure for the validation related protocols 
and reports, showing how each element of the file are managed prior to their 
approval release. 
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Figure 6.2. New documentation structure 
6.2.2.  Identification 
The implementation of “Job Route-cards” provides the ability for shop floor data-
collection within the manufacturing process, which will result in clearer and 
more accessible information for the subsequent process validation stage. 
At the end of this research period, first steps have been taken towards the 
implementation of this procedure within production. A template for the Shop 
Floor Data Collection card has been validated by the engineers and operators 
involved in the manufacturing process. The content and data-fields of the card 
has been linked to the information database through the current production ERP 
system, assuring the accuracy of the data and providing performance metrics, 
transparency and full-traceability. 
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6.2.3.  Communication procedures 
One of the factors identified in the benchmarking analysis which has enhanced 
the efficiency and quality of the validation process and other related ones in the 
company is the update of the flow of communication and information within the 
relevant department. 
This is way this area required the most immediate action at the manufacturing 
company, hence it is highly recommended that the flow of information between 
the departments involved in process validation, quality assurance and 
production, in particular shall be improved. 
In order to address this challenge, several modifications were made during this 
research project period: 
- Update of internal procedures: e.g. confirmation meetings acting as 
“checkpoints” before major changes during the work-flow, intermediate 
and final review stages for newly produced documentation. 
- Implementation of new communication channels: improvement of current 
IT infrastructure, implementation and use new on-line collaborative 
software tools and “in-the-cloud” services. 
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6.2.1.  Risk management 
During this research project period, FMEA related procedures and work-flow 
were updated in order to address the outcomes of the benchmarking study. For 
example, Figure 6.3 shows an updated template for the FMEA analysis, which 
contributed in simplifying the process, minimising the time spent on 
documentation activities and enhancing this risk assessment process within the 
organisation. 
In addition to this, the number of participants and different roles involved in the 
several analysis performed along the project was increased; resulting in more 
opinions and point of views for the different requirements evaluated in this 
process. 
Although, in a first moment, this resulted in an increment of the time spent on 
the meetings, the extra-resource investment resulted very useful. 
Figure 6.3. FMEA Template 
6.3.  LONG TERM SCENARIO 
In a similar way to the previous section, this one covers the practices which 
implementation and integration within the company would require: 
1. High amount of resources investment, effort, time or analysis due to its 
complexity, and/or; 
2. Benefits would be only appreciated after a reasonable period of time 
after the integration of such practices 
This way, a long-term scenario picture is depicted, requiring great commitment 
in both terms of resources allocation and management level consideration. 
83 
 
6.3.1.  ERP 
As it has been pointed out in along the benchmarking study, a total 
implementation of ERP system across the organisation would improve the 
efficiency and create an enhanced visibility of the different actions during the 
validation stage, providing transparency to the quality related issues, increasing 
the reliability of the documentation management, reducing risks and removing 
non-value adding processes to improve the efficiency of the department/s. 
However, opinions from the expert panel and external parts consulted reveal 
that the total implementation of the ERP solution across the relevant 
department/s involved in process validation might be an area which would 
require further assessment due to the huge investments associated. 
6.3.2.  Training 
The amount of resources required for developing a training course catalogue 
moves this proposal to a long term scenario. 
6.3.3.  Identification: Bar-code system 
The total implementation and successful integration of the previously mentioned 
Shop Floor Data Collection Cards will act as a trigger for the adoption of a bar-
code based capture solution and enabling the maximum optimisation of this 
resource. 
6.4.  SUMMARY 
This chapter has described the recommendations and considerations that need 
to be taken into account in order to implement the identified best practices 
within the organisation. Depending on the benefits expected, the time-frame 
considered, the complexity and the resources required, two different groups 
have been created.  
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7. DISCUSSION AND CONCLUSIONS 
7.1.  INTRODUCTION 
This final chapter describes the conclusions of this research project, showing 
the main research results, outcomes and potential benefits for the sponsor 
company and the related industrial sector community. 
A final evaluation of the research methodology is made and the subsequent 
findings and achievements of this project are summarised. 
In addition to this, the assessment of the contribution to knowledge is depicted 
based on the completion of the initial aim and objectives of this research project 
and the knowledge gained through its several phases. 
Finally, the applicability of the research results is evaluated and it is concluded 
with the discussion and recommendation of potential related work and projects 
in this area. 
7.2.  METHODOLOGY DISCUSSION 
The qualitative research methodology selected for this project has proved 
successful in capturing the required information to sketch and define the 
approach to the solutions for the defined objectives at the start of the project. 
First of all, the literature review has been helpful in identifying the first elements 
that should be considered when facing a benchmarking study and cross-
industry practices translation project, highlighting the importance of selecting 
the right methods and participants and providing an adequate number of case 
studies, previous benchmarking databases and specific practices. 
The sponsoring company internal analysis reviewed the organisation current 
practices, procedures and available resources for the process validation stage. 
This analysis provided the assessment of the current status, identified the 
improvement areas and defined the scope and considerations for the 
benchmarking study. 
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This extensive review was complemented with a cross-industry benchmarking 
study, which evaluated the process validation practices in the aerospace 
industry and the different procedures, resources and particular characteristics 
involved at this stage. In order to carry out this study, semi-structured 
questionnaires were adopted as the best tool for capturing the qualitative 
information and it can be concluded that these have been very efficient methods 
for this purpose, acquiring the opinion and information given by different 
representatives across the sector. The variety of roles and participants 
consulted provided several options of facing the same problem and permitted 
the definition of a wider scheme of solutions. In order to check that the obtained 
solutions were the most appropriate ones, complete validation of the outcomes 
was performed with experts’ opinion. 
Finally, the implementation within the organisation’s internal procedures of the 
results of this study was carried out, providing some practical real-life 
experience to the outcomes of this research. Due to time and resource 
considerations, not all the proposals were integrated in the sponsor company by 
the end of this period. 
The main limitations of the followed methodology for this research project were, 
first, the lack of any quantitative analysis or numerical method for comparison, 
which would have permitted a more accurate evaluation of the different 
practices and/or resources used during the validation stage. In addition to this, 
for the benchmarking study, the use of other available methods, such as on-line 
surveys or more on-site live visits would have provided a wider range of 
information and further richness for the purposes of this study. 
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7.3.  RESULTS DISCUSSION 
The aim of this research project was to perform a benchmarking study of the 
best practices within the aerospace sector for the development of an efficient 
process for the validation of medical devices. This aimed was achieved through 
a four-stage methodology focused on completing the four objectives established 
at the beginning of the research project. 
- Evaluate the current procedures for medical device manufacturing, 
looking for gaps and improvement areas. 
This objective was completed through the internal analysis stage, which 
identified the improvement areas for the sponsor company, as it has been 
described through the company internal analysis chapter (section 4) of this 
thesis. 
- Perform a cross-industry benchmarking study in order to identify the best 
practices for the validation process. 
The benchmarking study took into account the outcomes of the internal analysis 
and identified within the aerospace sector the best practices for the process 
validation stage, resulting in a set of procedures and resources that will 
contribute to the improvement of the performances of the organisation, as it has 
been described through the benchmarking study chapter (section 5) of this 
research project thesis. 
- Carry out validation, embedding assessment and implementation 
feasibility analysis of the identified methods. 
The results of the benchmarking study were evaluated and new practices and 
procedures were validated by a panel of experts formed by different key roles 
within the organisation and the process validation phase, resulting in a list of 
implementation proposal for the sponsoring company. 
- Develop a set of guidelines for the implementation of the new practices 
This objective was achieved by generating a set of guidelines for the proposals 
implementation, as it has been exposed through the implementation guidelines 
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on the section 6 of this thesis. Two different groups were identified, the short 
term recommendations, which would provide benefits and improvements on a 
short time scenario with a little amount of resource investment; and the long 
term considerations, which expected improvements and/or complexity required 
longer times or larger amount of resources. 
7.4.  CONTRIBUTIONS 
This research project puts into light a key aspect of the current industrial 
practice that affects to multiple sectors. Due to the increasing complexity of the 
products and the wider offer available, the medical device manufacturing 
organisations admit the importance of successful product development and the 
necessity of its optimisation. Within this process, the validation stage plays a 
crucial role that requires to be addressed before the production and 
commercialisation of the newly developed solution. 
The outcomes of this research project are based on an analysis of the leading 
practices of process validation across the aerospace industry and promotes the 
identification of: 
- The key points and procedures within the process validation stage in 
order to ensure the manufacturing of highly reliable and quality products. 
- The practices, knowledge and resources required to optimally address 
each activity through process validation. 
- The interactions and exchanges between these factors and how they 
shape and modify the process validation. 
In this way, appropriate procedures and resources required to make these 
happen are potential sources for the efficiency in the process validation stage.  
It has been demonstrated that organisations operating in the aerospace and 
defence industry have mainly adopted automated management solutions within 
the four main activity areas; documentation management, quality management, 
product and programme management and review process, resulting in dramatic 
improvements in the business performance and compliance with their relevant 
Regulatory Authority requirements. 
88 
 
On the other hand, medical device companies, while still delivering the required 
compliance, are still using combinations of paper-based processes and discrete 
IT solutions. The sponsor company uses a robust and consistent process 
validation strategy which has been proving to be successful when dealing with 
customer’s requirements; but the inadequate definition of some procedures 
result in a loss of valuable resources in non-value adding activities. Although 
correct decisions were made regarding the major points in process validation, 
the derived and subsequent activities were not optimised. 
The thesis pointed out the relevance of the configuration management related 
tasks within an organisation and its influence on the major activities of the 
business. 
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7.5.  FUTURE WORK 
It can be said that the principal limitation of the adopted approach was the lack 
of a quantitative or numerical analysis, due mainly to the diverse characteristics 
of the elements that were being compared. However, once particular areas 
have been highlighted in process validation, a numerical method for rating the 
different parameters involved may be helpful in assessing the effectiveness the 
adopted practices. 
As a further development of the previous statement, by dealing with specific 
case studies, such quantitative analysis and direct comparisons and 
measurements could provide more accurate data regarding the different 
improvements obtained from their implementation. 
Further research activities could be performed within the new process validation 
framework recently released (2011) by the FDA, evaluating and addressing the 
new challenges that medical companies need to face and the internal updates 
of the organisation associated with these changes (philosophy, procedures, 
resources, etc.). In a similar way to the aim of this thesis, learning from 
aerospace and implementing into medical device manufacturing; the research 
of how aerospace companies perform within the product life-cycle approach 
environment would provide key findings for its further implementation within the 
FDA’s 2011 approach framework. 
Finally, the scope of the benchmarking could be varied by evaluating the 
validation related practices within the medical device manufacturing sector or it 
could be potentially enlarged to consider a greater range of companies and 
sectors involved, adopting a broader and global approach. 
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7.6.  CONCLUSIONS 
Non-conformances, delays and different setbacks are frequently expected in the 
validation programme of a new product within the aerospace and medical 
device industry due to a range of reasons, such as configuration management, 
communication or resources. 
Aerospace and medical device manufacturing companies are required to 
automate compliance and quality processes to meet the relevant Regulatory 
Authority requirements, while improving business process performance and 
compliance integrity. 
This research identified issues in the process validation stage of a new medical 
device manufacturing programme. It also identified best practices from the 
aerospace sector based on an external study. In addition to this, it also 
highlighted the desirable resources required for undertaking these practices in a 
reliable way. Finally, this study provided the guidelines for the implementation of 
the identified practices and desirable resources. 
The resulting proposal defines a structured set of tools, practices, resources 
and capacities that should be improved within the organisation in order to face 
successfully the different requirements and challenges along the path of the 
process validation. 
The ultimate objective of this is to enable the organisation, and any other 
interested companies, to reduce the time to market of their products, reduce the 
associated costs while assuring the product quality and meeting the customer 
and regulatory requirements. 
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APPENDIX A – INTERNAL QUESTIONNAIRE 
 
  
Cranfield University – JEB Engineering Design Ltd. 
MSc by Research (Sample) 
 
INTERNAL QUESTIONNAIRE 
(JEB ENGINEERING QUALITY DEPARTMENT) 
This document is a sample of the semi-structured questionnaires used for the Internal 
Analysis in order to collect information regarding the internal procedures and passed to 
engineers, operators and/or other employees involved in the process validation for medical 
devices. 
Each interview/visit required preview personalisation of the set of the questions asked based 
on the role of the subject and its involvement along the process flow. 
 
INTRODUCTION 
Name:  
Job Title: 
Years of Experience/ in the Company: 
 
Can you describe your key responsibilities within medical Process Validation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
 
What are the key functions of the Department where you work? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
 
Which individuals/What elements (both internal and external) do you interact with in order to 
perform your job?  
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Cranfield University – JEB Engineering Design Ltd. 
MSc by Research (Sample) 
Could you please provide, a brief description, of a typical day in your work-day within the 
department? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
(Optional) If you have worked for other departments, how would you compare them to 
Quality Assurance Department? (Procedures, resources, responsibilities, work environment) 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What Responsibilities would you assign/release to the Quality Assurance Department? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
How would you define the current Quality Management System? (Manual, Procedures, 
Instructions, etc.) 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
 
* * * 
  
Cranfield University – JEB Engineering Design Ltd. 
MSc by Research (Sample) 
PROCESS VALIDATION 
How would you describe the current Process Validation system? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Could you please identify the Strength and Weaknesses? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
From the different stages of Process Validation, which one would you consider as the 
easiest one? The most difficult? Why? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Regarding the company internal procedures, would you change or update any of them? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What Reviews/Control Procedures are in place within your activity area? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What changes would you think that may improve the current process?  What changes would 
you make to the Process? (Procedures, practices, resources, strategy, etc.) 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
From the list given, which changes do you consider that are required to be urgently done? 
……………………………………………………………………………………………………..….. 
Cranfield University – JEB Engineering Design Ltd. 
MSc by Research (Sample) 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What are your key milestones regarding a Process Validation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Could you identify any part of the process which supposes a burden for the achievement of 
those milestones? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Do you work with key milestone reviews or regular meetings to the best and worst practice 
experienced on a validation project? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Can you describe any major or recurring problems/issues resulting from current practices of 
validation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What would you consider as the organisation’s best practices? (Name 5 of them, please) 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Is there anything else that you wish to add or discuss? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
* * *  
Cranfield University – JEB Engineering Design Ltd. 
MSc by Research (Sample) 
RESOURCES 
Which are your communication channels with other workers when performing Process 
Validation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
If unlimited resources were assigned to the Process Validation stage, which 3 things would 
you improve/acquire/change/delete first? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
If only one element could be applied to the current process, which one would it be if the 
objective is to reduce the time spent on Process Validation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What Tools/Software/Media do you use for the Process Validation related activities? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Which capacities/abilities do you consider as the appropriate ones/most helpful ones when 
facing a Process Validation project? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Would you consider / Would you be interested in Training Courses/Workshops if offered? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
* * * 
Cranfield University – JEB Engineering Design Ltd. 
MSc by Research (Sample) 
 
THANK YOU VERY MUCH FOR YOUR TIME AND CONSIDERATION 
 
NOTES: 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
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BENCHMARKING QUESTIONNAIRE 
This document is a sample of the generic semi-structured questionnaires used for the 
Benchmarking Study in order to collect information regarding the procedures within the 
aerospace sector regarding product validation and verification activities. 
Each interview/visit required preview personalisation of the set of the questions asked based 
on the role of the subject and its involvement along the process flow, so the content of this 
document may vary between interviews and interviewees. 
 
INTRODUCTION 
The objective of today’s interview is to discuss practices of process validation within your 
organisation. 
First of all, I would like to thank you for your time and consideration. 
Your identity (or your company’s) will not be revealed and all the data and information 
provided will be used for the purposes of this research project only and shall be treated with 
the strictest confidence and privacy. It will not be directly quoted or passed/sold to any third 
parties. 
This interview is structured in three main areas: 
1. Introduction 
2. Process Validation 
3. Resources 
It shall begin with general questions concerning your job activities, tasks, responsibilities and 
role within the validation and verification stage. 
Continuously, more specific questions will be asked regarding the practices and procedures 
followed within your organisation. 
Finally, this interview will conclude with some questions concerning the resources available 
for carrying out those tasks mentioned on the previous section. 
Again, thank you very much indeed for your time and collaboration. 
* * * 
Name: …………………………………………………………………………………………….. 
Job Title: ………………………………………………………………………………………….. 
Years of Experience/ in the Company: ……………………………………………………….. 
Previous experience / Career: …………………………………………………………………. 
 
This questionnaire is a common template and questions may vary. 
Cranfield University – Benchmarking Questionnaire 
MSc by Research (Sample) 
What is your role within the organisation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What department do you work for? What are the main responsibilities / functions of this 
department? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Which individuals / other departments / parts (both internal and external) do you usually 
collaborate with in order to perform your responsibilities? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Can you describe your key responsibilities within medical Process Validation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Could you please provide, a brief description, of a typical day in your work-day within the 
department? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What Responsibilities would you assign/release to your current Deparment? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
 
* * * 
PROCESS VALIDATION 
Cranfield University – Benchmarking Questionnaire 
MSc by Research (Sample) 
How is the Validation & Verification stage of the products performed at your organisation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Could you please define/quantify how your involvement is in V&V process within your 
organisation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
How would you describe the role of V&V within the development of a new product? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
How would you define the status of the V&V activities that are performed at your company? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What individuals or functions are involved through the stages of process validation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Please, describe briefly a typical “Process Validation” procedure within your company. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What practices / procedures / resources are in place in order to assure traceability / 
identification of the elements involved within product development? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Cranfield University – Benchmarking Questionnaire 
MSc by Research (Sample) 
……………………………………………………………………………………………………..….. 
What Reviews/Control Procedures are in place within your activity area? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What changes would you think that may improve the current process?  What changes would 
you make to the Process? (Procedures, practices, resources, strategy, etc.) 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
From the list given, which changes do you consider that are required to be urgently done? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Which Risk Assessment tools do you use in your organisation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
(Optional) Do you carry out FMEA at any stage of your process? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
(Optional) Could you describe the FMEA procedures within your organisation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Could you identify any part of the process which supposes a burden for the achievement of 
those milestones? 
……………………………………………………………………………………………………..….. 
Cranfield University – Benchmarking Questionnaire 
MSc by Research (Sample) 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Do you work with key milestone reviews or regular meetings to the best and worst practice 
experienced on a validation project? How are these performed? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Can you describe any major or recurring problems/issues resulting from current practices of 
validation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Could you describe the primary causes of setbacks / delays / non-conformances / other 
problems during the validation process and activities? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What would you consider as the organisation’s best practices? (Name 5 of them, please) 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Is there anything else that you wish to add or discuss? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
* * *  
Cranfield University – Benchmarking Questionnaire 
MSc by Research (Sample) 
RESOURCES 
Which are your communication channels with other workers when performing Process 
Validation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
How would you describe your Documentation system? Would you change any of it? If so, 
what, why? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What the average time you spent on creating documentation for validation activities? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
How would you describe your IT infrastructure? Strength, Weakness? What would you 
improve / change? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
If unlimited resources were assigned to the Process Validation stage, which 3 things would 
you improve/acquire/change/delete first? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
If only one element could be applied to the current process, which one would it be if the 
objective is to reduce the time spent on Process Validation? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Cranfield University – Benchmarking Questionnaire 
MSc by Research (Sample) 
How many people are assigned to your department? How many of them participate directly 
in validation process activities? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
What Tools/Software/Media do you use for the Process Validation related activities? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
Which capacities/abilities do you consider as the appropriate ones/most helpful ones when 
facing a Process Validation project? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
How is Training / Human Resources development programme performed in your company? 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
* * * 
 
THANK YOU VERY MUCH FOR YOUR TIME AND CONSIDERATION 
 
  
Cranfield University – Benchmarking Questionnaire 
MSc by Research (Sample) 
NOTES: 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
……………………………………………………………………………………………………..….. 
